rfhg_196345.1

Basic information about the TSS

---

TSS ID: rfhg_196345.1 Species: human Chr: chr17		Start: 58005475 End: 58005494 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2946679,EH38E1873822)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: MF436148:188 GeneID: 6426 HGNC/MGI_ID: HGNC:10780 UniProt_ID: Nearer transcript ids and distances:

Gene_name: SRSF1 Gene_symbol: SRSF1 Gene_synonyms: ASF MGC5228 SF2 SF2p33 SRp30a Gene_source: HGNC:10780

TATA-Box annotation

---

Distance to TSS:	1762
Nearest PromoterID:	NM_006924
Entrez ID:	6426
Nearest Unigene:	Hs.68714
Nearest Refseq:	NM_006924
Nearest Ensembl:	ENSG00000136450
Gene Name:	SRSF1
Gene Alias:	ASF|SF2|SF2p33|SFRS1|SRp30a
Gene Type:	protein-coding
CpG%:	0.052632
GC%:	0.550000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SRSF1 p3@SRSF1 p4@SRSF1 p5@SRSF1 p6@SRSF1 p7@SRSF1 p8@SRSF1 p9@SRSF1 p10@SRSF1
Sample		p1@SRSF1	p3@SRSF1	p4@SRSF1	p5@SRSF1	p6@SRSF1	p7@SRSF1	p8@SRSF1	p9@SRSF1	p10@SRSF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	168.12	11.49	4.29	0.97	0.97	2.92	3.31	1.75	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	173.18	9.10	4.65	1.01	0.61	3.64	3.03	2.02	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	180.56	10.03	6.17	0.77	1.16	3.28	3.67	1.54	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	159.26	15.18	6.24	0.00	1.25	3.53	2.29	1.66	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	161.08	13.50	5.40	0.90	0.00	4.27	4.50	2.25	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	162.61	15.12	4.26	0.39	0.19	2.91	1.74	1.36	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	257.32	15.47	6.54	1.09	1.31	6.75	3.70	1.96	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	220.90	12.35	4.60	1.21	1.21	4.60	4.12	1.94	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	205.17	9.19	3.21	0.43	0.64	3.42	2.35	2.99	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	106.65	9.85	6.38	0.58	1.16	4.06	0.58	3.48	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	113.59	10.11	13.34	0.00	0.81	1.62	2.02	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	119.53	10.16	8.54	0.00	0.81	2.03	0.81	2.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	95.59	0.64	0.16	0.97	1.13	2.74	0.81	0.48	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	87.50	1.50	0.00	0.30	0.30	2.26	1.95	0.45	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	71.57	0.66	0.22	0.22	0.00	2.63	0.44	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	71.93	0.50	0.00	0.50	0.75	1.76	0.25	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	59.19	0.87	0.00	0.44	0.22	1.53	0.22	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	47.67	0.42	0.00	0.42	0.00	2.11	1.27	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	48.52	0.00	0.00	0.00	0.00	1.60	0.00	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	81.69	0.90	0.00	0.45	0.30	1.81	1.50	0.60	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	84.47	0.67	0.00	0.13	0.13	1.87	1.34	0.40	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	72.67	1.73	0.00	0.35	0.52	2.24	1.21	0.17	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	66.18	0.39	0.26	0.13	0.52	1.29	1.16	0.78	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	68.43	0.49	0.49	0.24	0.00	2.43	1.94	0.49	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	74.82	1.29	0.00	0.52	0.77	2.06	0.77	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	60.14	0.32	0.00	0.32	0.32	1.90	0.32	0.95	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	68.68	1.10	0.00	1.65	0.55	2.75	0.55	1.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	89.59	0.94	0.24	0.71	0.71	1.65	1.41	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	64.61	0.97	0.16	0.16	0.32	2.42	0.97	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	89.04	0.36	0.00	1.27	0.36	3.26	1.45	0.36	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	77.25	1.47	0.00	0.63	0.00	2.51	2.09	1.05	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	75.42	0.98	0.00	0.59	0.59	2.34	0.98	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	66.47	1.06	0.00	0.21	0.42	2.95	2.32	1.06	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	82.30	0.49	0.16	0.66	0.33	4.29	1.81	2.14	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	80.22	0.19	0.00	0.75	0.19	2.99	1.68	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	85.08	0.38	0.19	0.77	0.38	2.49	1.53	0.96	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	79.50	0.82	0.20	0.82	0.41	2.45	1.84	0.61	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	74.95	0.40	0.00	0.20	0.40	2.01	1.01	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	72.12	1.08	0.00	0.81	0.54	2.43	0.81	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	76.82	0.48	0.00	0.24	0.00	2.40	1.20	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	72.22	0.47	0.24	0.24	0.24	2.35	0.71	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	80.22	1.02	0.00	0.73	0.44	2.93	0.88	0.88	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	85.20	0.42	0.00	1.27	0.84	1.90	1.27	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	68.36	0.17	0.35	0.52	0.35	2.97	1.40	1.22	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	78.50	0.80	0.20	0.60	0.60	1.20	0.40	0.60	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	76.77	1.86	0.00	1.40	0.70	3.95	0.93	2.33	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	78.21	0.96	0.00	0.24	0.24	1.44	1.20	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	70.94	0.30	0.30	0.30	0.30	1.19	1.49	0.89	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	79.71	0.24	0.24	0.48	0.48	2.15	0.24	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	75.02	0.61	0.00	0.20	0.40	0.61	1.21	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	79.93	0.61	0.00	0.41	0.20	2.25	1.02	1.43	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	104.96	0.89	0.22	0.89	0.67	3.56	1.11	1.56	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	405.77	0.00	13.99	13.99	13.99	0.00	13.99	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	92.26	0.00	0.35	0.35	0.35	1.06	1.77	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	105.38	0.33	0.00	0.33	0.66	1.99	1.33	2.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	134.23	0.84	0.00	5.03	0.84	13.42	2.52	8.39	8.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	86.34	0.92	0.00	0.92	0.92	6.43	1.38	3.67	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	118.62	0.32	0.00	0.65	0.32	1.94	1.30	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	114.34	0.64	0.00	0.64	0.00	1.28	0.64	1.28	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	112.53	2.51	0.00	1.89	0.31	7.54	3.46	4.09	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	112.10	0.00	0.00	0.71	0.00	0.71	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	91.41	0.56	0.00	0.56	0.56	2.80	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	80.41	1.59	0.00	3.98	0.00	13.53	0.00	7.17	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	82.90	1.70	0.00	0.34	0.68	4.08	0.68	1.02	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	111.45	0.00	0.32	0.32	1.30	1.62	0.97	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	75.61	0.35	0.00	1.06	0.35	1.77	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	290.95	0.00	0.00	0.00	0.00	0.00	32.33	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	252.72	0.00	0.00	0.00	15.79	39.49	0.00	15.79	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	56.06	0.00	0.00	0.49	0.00	1.95	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	61.49	0.99	0.50	0.00	0.99	1.49	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	68.96	0.00	0.00	0.00	0.00	0.00	0.00	1.41	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	79.15	0.33	0.00	0.66	0.33	1.66	1.32	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	68.36	0.00	0.62	1.24	0.00	1.86	0.62	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	71.85	0.31	0.00	0.31	0.31	0.61	1.53	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	57.65	0.16	0.00	0.32	0.16	1.11	0.32	0.63	0.63
Adipocyte - breast, donor2	11327-117E4	55.35	0.16	0.00	1.44	0.16	2.09	0.96	1.28	0.64
Adipocyte - omental, donor1	11473-119C6	55.22	0.25	0.00	0.38	0.13	1.65	0.38	0.13	0.51
Adipocyte - omental, donor2	11474-119C7	30.65	0.00	0.00	0.75	0.00	2.99	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	45.88	0.00	0.00	0.67	1.00	2.01	0.67	0.67	1.67
Adipocyte - perirenal, donor1	11476-119C9	37.64	0.00	0.00	0.64	0.64	0.64	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	65.03	0.00	0.00	0.90	0.45	2.26	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	38.23	0.35	0.00	0.17	0.35	0.70	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	93.09	0.59	0.00	0.20	0.20	0.98	0.78	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	68.46	0.26	0.00	0.26	0.00	1.29	0.51	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	81.12	0.28	0.00	0.56	0.00	1.12	0.84	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	75.24	0.00	0.00	0.00	0.00	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	98.45	0.48	0.00	0.00	0.16	0.88	0.24	0.16	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	62.61	0.32	0.00	0.00	0.00	0.00	0.32	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	65.58	0.53	0.00	0.53	0.53	2.13	1.60	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	68.44	0.00	0.00	0.00	0.56	0.56	1.67	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	72.78	0.00	0.00	0.00	0.00	0.00	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	60.28	1.00	0.00	0.50	0.00	0.75	0.25	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	65.12	0.00	0.00	0.98	0.65	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	66.37	0.30	0.00	0.00	0.00	0.61	0.00	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	87.07	0.66	0.22	0.00	0.00	0.44	0.44	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	36.58	0.72	0.00	0.00	0.00	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	80.24	0.90	0.00	0.54	0.18	1.08	0.36	0.90	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	51.88	1.67	0.00	0.00	0.00	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	53.62	0.21	0.00	0.00	0.21	0.21	0.41	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	58.81	0.11	0.00	0.57	0.23	0.11	0.23	0.34	0.46
Anulus Pulposus Cell, donor2	11463-119B5	39.43	0.00	0.00	0.00	0.24	0.98	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	48.07	0.00	0.00	0.00	0.00	0.00	0.45	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	55.14	0.43	0.00	0.43	0.00	1.74	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	0.00	0.00	2.14	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	51.41	0.00	0.00	0.00	0.00	0.90	0.90	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	51.85	0.00	0.00	1.26	0.00	2.53	2.53	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	40.92	0.00	0.00	0.00	0.00	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	45.81	0.00	0.00	0.65	0.32	0.00	0.65	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	48.06	0.00	0.00	0.00	0.00	1.46	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	45.73	0.00	0.00	0.00	0.00	2.38	1.19	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	47.46	0.75	0.00	0.00	0.75	1.88	1.88	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	56.60	0.00	0.00	0.73	0.73	1.45	1.45	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	33.85	0.00	0.00	0.00	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.20	0.66	0.00	0.16	0.00	1.15	0.66	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	68.24	0.00	0.00	0.00	0.00	1.36	0.00	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	41.92	0.30	0.00	0.15	0.00	1.06	0.90	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	54.11	0.54	0.00	1.07	0.00	1.07	2.14	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	55.36	0.00	0.00	0.57	0.00	1.70	1.32	0.19	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	50.78	0.27	0.00	0.27	0.00	0.80	2.41	1.34	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	59.50	0.00	0.00	0.00	0.98	1.95	2.93	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	47.10	0.00	0.00	0.33	0.00	0.33	0.17	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	38.42	1.20	0.00	1.20	0.00	1.20	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	48.89	0.17	0.00	0.34	0.17	0.51	0.34	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	71.31	0.00	0.00	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	46.12	0.00	0.00	0.00	0.49	0.00	2.43	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	48.19	0.00	0.00	0.00	0.00	0.38	1.90	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	49.67	0.00	0.00	1.21	0.00	0.00	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	47.31	0.00	0.00	0.57	0.00	0.00	2.28	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	46.82	0.21	0.00	0.86	0.21	0.21	0.64	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	39.23	0.00	0.00	0.26	0.77	0.52	1.03	0.26	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	53.96	0.00	0.00	0.47	0.00	0.00	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	45.34	0.00	0.00	0.64	0.00	1.29	1.61	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	52.80	0.71	0.00	0.71	0.00	0.71	2.14	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	43.29	0.58	0.00	1.75	0.00	0.58	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	51.48	0.30	0.00	0.60	0.00	0.90	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	55.84	1.19	0.00	0.00	0.00	2.38	3.56	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	59.50	0.51	0.00	0.00	0.00	0.51	2.03	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	55.27	0.25	0.00	0.00	0.00	1.02	1.78	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	41.93	0.00	0.00	0.00	0.00	0.00	0.64	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	51.35	0.00	0.00	0.43	0.00	1.73	1.73	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	48.90	0.42	0.00	0.42	0.21	0.64	0.42	0.00	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	39.15	0.29	0.00	0.58	0.29	0.00	0.87	0.00	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	45.35	0.00	0.00	0.00	0.00	2.83	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	43.06	0.00	0.17	0.34	0.17	0.51	0.68	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	0.00	0.00	0.00	0.00	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	63.38	0.00	0.00	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	47.60	0.00	0.21	0.00	0.64	1.29	0.00	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	45.73	0.00	0.00	0.00	0.00	1.20	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	48.84	0.00	0.00	0.00	0.73	2.92	1.46	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	44.60	0.00	0.00	0.23	0.00	0.23	1.38	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	0.00	0.00	5.10	0.00	5.10	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	41.19	0.51	0.00	0.25	0.00	1.02	0.76	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	49.34	0.00	0.00	0.41	0.21	0.21	1.45	0.41	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	45.90	0.31	0.00	0.61	0.31	0.61	0.31	0.92	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	54.02	0.00	0.00	1.43	0.00	2.39	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	45.46	0.67	0.00	0.22	0.00	0.67	0.22	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	1.53	0.00	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	44.31	0.00	0.00	0.55	0.00	1.11	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	55.61	0.53	0.00	0.26	0.53	0.79	0.26	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	41.07	0.00	0.00	0.36	0.36	0.36	1.45	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	100.83	0.98	0.25	0.37	0.25	0.74	0.49	0.61	0.61
Astrocyte - cerebellum, donor2	11580-120F5	83.01	0.34	0.00	0.51	0.34	0.51	0.51	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	36.71	0.63	0.21	0.21	0.00	0.21	0.00	0.63	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	150.94	0.70	0.35	1.05	0.00	1.39	1.05	1.39	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	172.94	1.29	0.81	1.46	1.78	2.91	2.10	1.13	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	191.82	2.54	0.60	1.34	0.60	1.79	1.04	1.49	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	278.57	6.88	0.23	2.87	0.57	2.98	4.01	1.38	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	307.32	8.64	0.50	2.00	1.13	1.75	3.13	0.88	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	287.11	7.85	0.34	2.39	0.57	1.93	2.73	1.02	0.68
Basophils, donor1	12241-129G9	38.71	0.26	0.00	0.00	0.00	0.52	0.00	0.00	0.00
Basophils, donor2	12242-129H1	54.12	0.36	0.00	0.00	0.00	0.72	0.36	0.00	0.00
Basophils, donor3	12243-129H2	48.07	0.29	0.00	0.00	0.44	0.15	0.15	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	29.11	0.22	0.00	0.00	0.00	0.22	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	16.00	0.00	0.00	0.00	0.00	0.46	0.00	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	79.08	1.26	0.63	0.00	0.00	0.00	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	69.66	0.83	0.21	0.00	0.00	0.42	0.00	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	43.76	0.00	0.00	0.23	0.00	0.46	0.69	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	40.49	0.00	0.00	0.00	0.36	0.18	0.54	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	290.20	4.53	1.03	1.13	0.52	1.65	0.62	1.13	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	256.89	3.96	1.40	0.23	0.70	3.03	1.63	0.23	2.56
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	164.36	1.28	0.64	0.32	0.00	0.64	0.64	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	144.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	37.19	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	42.69	0.00	0.00	0.37	0.19	0.37	0.19	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	54.88	0.00	0.22	0.00	0.22	0.44	0.22	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	75.57	0.28	0.00	0.00	0.28	1.13	0.00	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	67.48	0.00	0.00	0.38	0.00	1.90	1.14	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	79.88	0.33	0.00	0.00	1.31	1.31	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	77.33	0.29	0.00	0.87	0.43	1.16	0.87	0.14	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	60.95	0.91	0.00	0.30	0.30	1.51	0.30	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	77.70	0.47	0.00	0.95	0.47	0.24	0.00	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	55.74	0.17	0.00	0.67	0.00	1.51	1.17	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	54.93	0.00	0.00	0.00	0.28	0.55	0.00	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	62.23	0.25	0.00	0.00	0.00	0.99	0.50	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	50.32	0.00	0.00	0.78	0.20	0.59	0.78	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	46.47	0.18	0.00	0.36	0.18	0.53	0.00	0.18	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	58.98	0.22	0.00	0.65	0.22	2.18	0.44	0.22	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	43.31	0.00	0.00	0.23	0.00	1.40	0.00	0.23	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	63.36	0.00	0.00	0.53	0.53	2.64	0.53	0.53	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	57.69	0.00	0.00	0.00	1.11	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	56.23	0.45	0.00	0.30	0.00	2.08	0.15	0.30	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	66.05	0.40	0.00	0.60	0.60	1.00	1.00	1.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.91	0.42	0.00	0.62	0.62	1.46	1.04	0.62	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	49.19	0.46	0.00	0.46	0.23	1.14	0.00	0.92	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	45.47	0.00	0.00	0.68	0.68	0.90	0.00	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	51.07	0.87	0.00	0.00	0.00	0.44	0.00	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	52.99	0.00	0.00	0.81	0.00	0.81	0.54	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	55.83	0.00	0.00	0.35	0.52	0.52	0.87	0.52	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	46.29	0.84	0.00	0.84	0.42	0.00	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	38.40	0.00	0.00	1.10	0.55	1.47	0.55	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	59.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	59.67	0.44	0.00	0.00	0.88	0.88	0.88	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	45.34	0.00	0.00	0.17	0.17	1.22	0.87	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	44.97	0.00	0.00	1.12	1.49	1.12	0.74	0.74	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	63.59	0.86	0.00	0.22	0.22	0.43	0.65	1.08	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	53.64	0.00	0.00	1.23	0.82	0.41	0.82	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	50.07	0.00	0.00	0.23	0.23	0.23	0.00	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	51.97	0.00	0.00	0.23	0.23	0.46	0.23	0.93	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	67.13	0.00	0.00	0.87	0.00	0.22	0.87	1.09	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	63.29	0.00	0.00	0.23	0.23	0.00	0.69	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	61.52	0.22	0.00	0.00	0.43	0.65	0.22	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	75.84	0.00	0.00	1.56	0.00	0.78	0.16	0.93	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	69.68	0.17	0.00	0.00	0.00	1.75	0.52	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	80.71	0.00	0.00	0.67	0.00	0.67	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	63.03	0.26	0.00	0.77	0.00	1.53	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	61.48	0.22	0.00	0.66	0.44	0.88	1.32	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	64.43	0.00	0.00	0.21	0.00	0.63	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	148.36	0.00	0.00	0.00	0.00	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	191.19	0.00	0.00	0.00	1.36	0.68	2.03	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	165.70	0.00	0.00	0.00	0.00	1.04	0.00	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	117.80	0.00	0.00	0.53	0.00	1.07	1.07	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	213.35	1.07	0.00	1.61	0.00	1.61	1.07	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	193.03	0.70	0.00	0.00	0.00	0.70	1.40	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	192.17	0.00	0.00	0.78	0.00	0.00	3.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	214.88	0.00	0.00	0.00	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	98.63	1.64	0.00	0.00	0.00	1.64	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	82.70	0.00	0.00	0.00	0.00	0.73	1.45	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	85.32	1.01	0.00	0.50	1.01	0.50	0.50	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	267.89	7.27	0.81	3.23	0.40	3.64	1.62	1.21	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	184.17	3.99	0.80	1.60	0.80	0.80	2.00	2.40	1.20
CD34+ Progenitors, donor1	11545-120B6	52.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	74.72	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	250.63	1.88	0.75	1.13	0.38	1.88	0.75	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	224.36	1.35	0.23	0.23	0.23	1.58	0.45	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	111.40	2.14	0.00	0.00	0.36	0.71	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	103.49	1.22	0.00	2.45	0.00	0.61	1.22	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	76.25	0.91	0.00	0.30	0.91	1.83	0.00	0.61	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	152.89	0.00	0.00	0.26	1.28	3.06	2.04	0.26	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	128.02	0.67	0.00	0.67	0.45	2.92	0.67	1.35	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	131.66	0.00	0.00	0.29	0.86	0.86	0.86	0.86	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	156.92	0.95	0.00	0.47	0.00	0.95	1.42	0.95	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	205.08	0.00	0.00	0.70	0.70	1.40	1.40	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	184.59	3.30	0.00	0.00	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	122.26	0.87	0.00	1.45	0.72	2.02	1.16	1.16	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	133.88	0.51	0.00	0.68	0.85	2.71	1.02	1.02	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	120.58	0.48	0.00	1.13	0.48	1.45	1.29	0.32	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	97.28	1.34	0.00	0.00	0.00	1.34	0.45	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	119.49	1.75	0.00	0.70	0.70	0.35	2.10	0.35	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	128.03	0.00	0.00	0.44	0.44	1.76	1.32	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	122.70	1.69	0.00	0.42	0.84	4.64	1.26	2.11	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	132.14	0.83	0.00	0.42	0.42	2.29	0.62	1.45	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	121.96	1.34	0.00	0.67	1.00	3.34	1.34	1.34	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	169.96	1.90	0.00	0.82	1.90	1.90	1.36	0.27	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	216.52	0.54	0.00	1.61	2.14	3.22	3.75	1.07	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	190.08	0.00	0.00	0.00	0.00	3.59	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	165.03	1.30	0.00	1.11	1.11	2.97	0.93	0.37	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	136.47	0.43	0.00	1.30	0.43	1.08	1.08	0.22	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	131.98	1.89	0.00	1.26	0.21	1.89	0.63	1.26	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	108.20	1.52	0.00	0.00	0.00	1.01	0.51	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	134.31	1.73	0.00	0.43	0.43	0.87	3.47	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	132.05	0.00	0.00	2.18	0.87	2.61	1.74	1.74	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	226.16	0.00	0.00	0.49	0.99	1.48	1.48	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	203.10	0.00	0.00	0.92	0.92	0.00	1.85	2.77	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	234.50	0.00	0.00	0.00	0.00	0.00	2.79	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	196.62	1.11	0.00	1.38	0.55	2.22	1.38	1.11	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	238.52	0.49	0.00	1.47	0.00	1.96	1.47	1.23	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	212.52	1.54	0.00	0.00	1.54	0.00	4.62	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	242.09	0.00	0.00	0.00	0.72	1.07	2.15	1.43	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	256.22	1.38	0.00	0.00	0.00	2.77	5.54	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	87.74	1.31	0.00	0.00	0.98	0.65	0.00	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	92.36	1.13	0.00	0.38	0.38	1.88	0.00	1.13	1.50
CD8+ T Cells, donor3	11383-118B6	122.96	1.51	0.00	0.50	1.51	2.02	0.25	1.01	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	106.90	2.06	0.23	0.46	0.46	1.61	2.29	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	98.25	1.20	0.00	0.72	0.24	1.20	1.20	0.96	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	97.40	2.19	0.00	0.27	0.55	1.64	1.09	1.37	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	115.58	1.50	0.30	0.00	0.60	0.90	1.50	2.10	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	100.31	3.84	0.00	1.20	0.48	1.20	0.24	0.48	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	97.32	2.05	0.00	0.23	0.00	1.59	1.59	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	150.14	3.48	0.43	0.43	0.43	1.09	0.87	0.43	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	155.55	2.90	0.53	0.53	1.32	2.11	0.79	1.05	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	157.13	1.17	0.23	0.47	0.23	2.11	1.41	1.41	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	138.86	1.81	0.30	0.91	1.21	3.02	1.21	2.72	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	140.89	2.61	0.29	0.00	1.16	2.61	2.03	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	155.33	1.60	1.07	0.00	0.00	2.13	2.66	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	111.63	1.31	0.00	0.44	0.00	0.00	1.31	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	105.20	0.46	0.91	0.00	0.00	0.91	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	83.54	0.75	0.00	0.00	0.00	2.24	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	101.56	1.80	0.00	0.00	1.44	1.08	0.72	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	98.69	2.30	0.29	0.00	0.29	0.86	1.44	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	88.62	1.41	0.47	0.00	0.00	1.18	0.71	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	185.39	2.22	0.32	0.63	0.95	0.63	0.95	2.22	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	187.92	2.15	0.31	0.00	1.23	2.77	2.77	2.46	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	160.61	1.92	0.32	0.96	0.64	0.64	0.96	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	136.16	0.76	0.00	0.76	0.76	1.15	2.68	1.91	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	121.78	0.79	0.00	0.39	0.00	0.79	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	108.92	0.76	0.00	0.00	0.00	1.51	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	179.06	3.21	0.00	0.00	0.00	3.21	2.41	4.01	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	186.05	2.10	1.40	0.00	2.10	2.80	2.10	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	187.33	4.01	0.00	0.00	3.01	2.00	2.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	53.00	0.00	0.00	0.00	0.00	3.66	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	67.20	0.00	0.00	0.49	0.00	0.49	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	71.03	0.42	0.00	0.00	0.11	0.32	0.11	0.42	0.21
Chondrocyte - de diff, donor1	11261-116G1	76.61	1.39	0.00	1.39	0.35	1.04	0.69	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	44.78	0.36	0.00	0.00	0.00	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	64.63	0.68	0.00	0.34	0.34	1.48	0.91	0.46	0.57
Chondrocyte - re diff, donor2	11339-117F7	125.34	0.90	0.00	0.90	0.90	1.79	0.00	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	51.76	0.40	0.00	0.40	0.00	1.21	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	129.79	1.03	0.46	0.92	0.57	1.15	0.57	0.69	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	99.83	0.86	0.21	0.64	0.64	1.92	2.57	0.86	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	114.34	0.97	0.00	0.80	0.62	1.95	1.24	0.62	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	89.13	2.20	0.00	0.18	0.46	0.28	0.83	0.28	0.18
Corneal Epithelial Cells, donor1	11526-119I5	27.23	0.00	0.22	0.00	0.00	0.00	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	50.05	0.00	0.00	0.00	0.00	0.00	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	58.03	0.00	0.00	0.00	0.00	0.77	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	51.67	0.00	0.00	0.00	0.00	0.50	0.33	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	63.40	0.32	0.00	0.00	0.00	1.26	1.26	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	75.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	57.77	0.32	0.00	0.32	0.32	1.08	0.54	0.43	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	81.65	0.68	0.00	0.34	0.00	0.00	0.00	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	91.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	77.43	0.97	0.00	0.48	0.00	0.00	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	88.72	0.00	0.17	0.33	0.33	0.33	0.17	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	62.20	0.00	0.00	0.00	0.00	0.00	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	70.13	0.28	0.00	0.00	0.00	0.57	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	77.06	0.00	0.00	0.00	0.79	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	52.65	0.58	0.00	0.00	0.00	0.00	0.58	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	96.93	0.47	0.00	0.71	0.24	0.47	0.24	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	99.23	0.18	0.00	0.35	0.00	0.70	1.23	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	51.42	0.22	0.00	0.22	0.00	0.89	0.66	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	75.46	0.30	0.00	0.00	0.91	0.00	0.00	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	67.94	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	39.82	0.00	0.00	0.30	0.30	0.30	0.30	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	49.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	43.39	0.00	0.00	0.00	0.14	0.57	0.28	0.00	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	115.63	0.40	0.00	1.20	0.40	0.40	1.20	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	50.32	0.52	0.00	0.00	0.00	0.00	1.05	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	181.65	0.62	0.00	1.37	0.62	1.74	0.99	0.62	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	120.36	0.22	0.00	0.22	0.22	0.22	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	155.35	0.24	0.00	0.12	0.12	0.37	1.22	0.85	0.12
Endothelial Cells - Vein, donor1	11267-116G7	83.04	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	83.12	0.00	0.70	0.00	0.70	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	126.55	0.63	0.31	0.47	0.16	1.26	1.41	0.63	0.16
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	67.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	24.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	32.50	0.00	0.00	0.00	0.00	0.49	0.00	1.22	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	0.00	0.00	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	42.28	0.00	0.00	0.41	0.41	0.41	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	28.03	0.11	0.00	0.11	0.33	1.53	0.44	1.53	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	51.24	0.22	0.00	0.11	0.11	1.41	1.63	1.08	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	91.32	0.24	0.24	1.09	0.61	2.43	2.06	0.36	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	140.29	0.41	0.14	0.41	0.41	0.27	0.82	0.41	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	61.80	0.42	0.00	0.63	0.32	1.48	0.95	0.95	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	84.84	0.53	0.00	0.79	0.26	2.63	0.53	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	105.31	1.33	0.33	0.66	0.66	1.66	1.66	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	81.65	0.91	0.00	1.36	0.00	0.91	2.27	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	52.30	1.52	0.76	0.00	0.00	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	44.16	0.00	0.00	0.32	0.32	0.00	0.79	0.63	0.32
Fibroblast - Cardiac, donor4	11452-119A3	97.60	0.91	0.00	0.00	0.30	0.00	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	103.30	1.02	0.00	0.76	0.38	1.02	1.14	1.02	0.00
Fibroblast - Cardiac, donor6	11460-119B2	112.03	0.61	0.00	0.76	0.76	0.45	1.36	1.21	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	69.01	0.27	0.13	0.27	0.13	0.13	0.00	0.27	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	54.79	0.00	0.00	0.43	0.43	1.29	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	90.82	0.00	0.00	1.46	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	107.02	0.69	0.46	0.00	0.00	1.61	0.23	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	58.51	0.34	0.00	0.17	0.00	0.85	0.68	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	73.02	0.23	0.00	0.00	0.00	1.64	0.70	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	72.17	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	83.41	0.12	0.00	0.85	0.73	1.33	1.09	0.36	0.48
Fibroblast - Dermal, donor4	11450-119A1	143.23	0.90	0.11	0.90	0.90	0.90	2.26	0.90	0.34
Fibroblast - Dermal, donor5	11454-119A5	187.19	1.40	0.35	1.40	0.17	2.44	1.92	1.57	1.05
Fibroblast - Dermal, donor6	11458-119A9	204.65	2.92	0.16	2.44	0.49	1.62	2.27	0.81	0.65
Fibroblast - Gingival, donor1	11237-116D4	92.87	1.04	0.00	0.21	0.21	1.04	0.42	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	110.30	0.79	0.26	0.52	0.52	2.88	0.26	0.52	0.52
Fibroblast - Gingival, donor2	11318-117D4	158.40	1.19	0.00	1.58	0.53	1.98	3.29	1.19	0.26
Fibroblast - Gingival, donor3	11394-118C8	86.24	0.68	0.00	0.48	0.29	0.48	0.68	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	61.29	1.04	0.00	0.00	0.00	2.08	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	56.56	0.00	0.00	0.18	0.35	1.41	0.70	0.70	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	148.10	0.94	0.00	1.09	0.00	2.03	1.09	0.94	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	119.14	1.49	0.14	1.08	0.00	0.68	0.68	0.68	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	101.98	1.06	0.00	0.35	0.35	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	105.15	0.58	0.15	0.29	0.44	1.46	0.15	0.88	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	128.72	2.05	0.14	0.68	0.41	2.05	1.09	1.36	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	184.61	1.97	0.33	1.32	0.88	1.76	1.86	0.88	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	80.27	0.44	0.00	0.29	0.29	2.35	0.73	0.59	0.73
Fibroblast - Lung, donor1	11270-116H1	33.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	122.36	1.49	0.00	1.49	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	110.37	1.06	0.00	0.84	0.63	1.06	1.90	0.63	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	76.64	0.83	0.00	0.00	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	0.00	0.00	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	15.95	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	155.89	0.81	0.00	0.81	0.00	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	39.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	175.55	1.55	0.19	0.97	0.58	1.36	1.55	0.39	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	213.87	2.12	0.46	0.76	0.76	1.52	2.58	0.76	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	168.91	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	95.79	0.38	0.00	0.76	0.00	0.00	0.76	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	84.51	0.27	0.00	0.27	0.27	0.54	1.89	0.54	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	54.74	0.23	0.12	0.23	0.12	0.58	0.12	0.23	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	105.34	0.66	0.22	0.55	0.22	1.33	0.77	0.33	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	108.30	1.22	0.00	0.41	0.00	0.41	0.00	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	59.47	0.67	0.00	0.00	0.00	1.34	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	60.09	0.40	0.00	0.00	0.40	0.00	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	106.37	2.98	0.20	0.99	0.20	1.98	1.59	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	61.28	0.53	0.00	1.60	0.00	1.24	0.00	0.53	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	74.30	0.39	0.00	0.79	0.20	2.17	0.59	1.18	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	102.89	2.11	0.30	0.60	0.30	0.60	0.00	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	102.99	0.65	0.11	0.76	0.22	1.84	0.43	0.86	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	103.25	1.01	0.00	1.01	0.25	1.52	0.25	1.27	0.51
Fibroblast - skin normal, donor1	11553-120C5	65.96	0.82	0.00	0.82	0.00	0.66	0.16	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	138.55	1.80	0.00	0.60	0.60	1.20	0.40	0.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	88.61	0.50	0.10	0.80	0.40	1.51	0.70	0.90	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	115.45	1.81	0.00	3.02	0.60	3.02	1.21	0.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	71.58	0.66	0.08	0.33	0.17	1.16	0.58	0.17	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	79.66	0.51	0.00	0.68	0.51	1.03	0.51	0.34	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	90.32	0.66	0.00	0.00	0.00	2.63	0.66	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	91.08	0.85	0.00	0.53	0.43	1.92	0.85	1.28	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	120.78	1.52	0.00	0.84	0.51	2.02	0.17	0.51	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	49.56	0.47	0.16	0.47	0.16	2.04	1.41	0.78	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	487.52	0.00	0.00	0.00	0.00	44.32	0.00	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	98.48	0.00	0.00	0.87	1.74	0.87	0.00	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	74.54	0.52	0.35	0.17	0.52	0.69	0.00	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	88.22	0.26	0.00	0.26	0.78	1.04	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	94.03	0.51	0.00	0.26	0.00	0.26	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	171.48	4.59	8.42	2.30	3.06	9.19	2.30	0.77	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	230.34	9.57	7.02	3.19	0.00	8.93	11.49	3.19	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	282.13	9.98	8.27	5.71	1.71	15.97	3.71	1.71	4.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	242.11	6.89	1.65	3.03	2.21	18.48	2.21	3.58	5.79
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	185.40	4.79	0.91	2.74	1.14	15.53	2.05	3.88	3.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	237.36	8.52	3.76	2.97	0.59	11.10	4.16	2.38	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	217.02	6.87	1.32	1.59	1.06	27.23	1.85	3.17	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	196.67	5.54	0.98	0.33	0.98	7.50	0.98	1.30	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	205.19	5.31	7.08	3.98	3.10	10.61	1.33	3.54	4.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	147.26	4.66	3.53	1.98	1.27	4.66	2.40	1.41	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	122.40	1.85	1.35	1.85	0.49	2.34	1.35	1.60	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	127.60	3.22	0.81	1.88	0.54	1.34	1.61	2.42	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	115.10	1.36	0.87	1.36	0.62	3.84	1.12	1.61	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	114.48	2.77	0.28	1.11	0.69	2.49	1.80	2.35	2.77
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	107.75	1.42	1.83	0.61	0.20	1.63	2.85	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	83.97	1.83	0.91	1.14	0.91	1.60	0.68	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	91.80	1.87	0.62	0.50	0.12	1.74	1.99	0.87	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	87.21	1.31	0.66	0.44	0.22	1.09	0.87	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	87.46	2.07	0.59	1.18	0.30	2.07	0.59	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	126.85	2.54	0.32	1.27	1.43	4.61	2.23	2.23	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	86.46	2.01	0.45	0.89	0.22	0.45	0.67	0.67	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	124.41	2.82	0.60	1.21	0.40	3.63	2.62	2.02	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	136.73	2.21	0.17	1.36	0.34	3.56	1.87	2.21	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	133.81	2.75	1.33	0.44	0.27	2.22	0.35	0.98	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	99.37	1.35	0.21	0.10	0.52	0.94	0.31	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	88.29	1.37	0.17	0.17	0.17	0.85	0.34	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	116.63	1.00	0.11	0.89	0.77	2.10	0.89	1.44	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	133.20	2.58	0.75	0.67	0.33	1.41	0.75	0.58	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	125.37	1.63	0.41	0.20	0.20	1.23	0.61	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	97.79	1.03	0.00	1.03	0.41	1.44	1.03	1.24	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	111.37	1.15	0.58	1.04	0.35	3.57	1.50	1.04	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	120.74	1.33	0.33	0.67	0.33	1.33	1.17	1.33	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	61.94	0.44	0.00	0.44	0.00	0.88	0.66	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	88.80	0.98	0.12	1.60	0.25	2.21	0.98	1.35	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	116.87	2.11	0.32	0.81	0.32	1.46	1.30	1.62	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	66.07	0.96	0.32	1.28	0.00	0.32	0.64	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	90.21	0.95	0.19	0.76	0.47	2.18	1.04	1.04	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	77.19	0.79	0.00	0.79	0.32	0.79	0.16	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	83.02	1.82	0.30	0.30	0.00	1.82	1.22	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	98.68	1.25	0.21	1.78	0.10	2.51	1.05	1.25	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	73.33	0.00	0.22	0.66	0.00	1.32	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	72.66	0.28	0.28	0.56	0.00	1.68	0.84	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	95.55	0.46	0.37	1.20	0.28	1.85	0.37	1.30	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	81.83	1.60	0.00	0.27	0.00	1.87	0.80	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	99.15	1.38	0.46	1.07	0.31	1.53	0.77	1.07	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	101.95	1.17	0.26	1.30	0.39	1.17	1.17	1.55	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	66.41	0.00	0.00	0.27	0.27	1.08	0.54	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	75.40	0.37	0.00	0.92	0.00	2.03	1.47	0.74	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	66.45	0.44	0.00	0.22	0.88	1.10	1.10	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	78.35	0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	82.45	0.66	0.26	0.66	0.00	1.32	1.32	0.40	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	69.00	0.61	0.00	0.61	0.00	2.82	0.40	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	49.82	0.51	0.00	0.25	0.25	0.25	0.25	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	180.95	11.74	2.79	1.39	1.19	2.99	2.39	2.79	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	154.08	4.31	2.47	1.39	1.39	3.85	2.31	2.16	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	239.36	10.02	5.93	3.07	1.84	5.73	2.66	2.66	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	187.13	6.26	4.69	1.56	0.94	4.38	2.82	2.82	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	189.03	4.52	5.37	1.41	0.85	6.50	2.54	2.26	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	207.54	3.69	4.15	1.38	1.84	8.76	3.23	3.23	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	220.26	7.42	4.95	2.47	2.47	12.37	2.47	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	246.78	6.19	1.55	1.93	2.32	8.51	3.87	3.48	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	189.33	1.60	0.00	1.60	0.00	9.63	6.42	4.81	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	208.66	10.43	6.96	5.22	1.74	8.69	3.48	1.74	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	197.89	4.23	1.63	1.95	0.33	10.42	2.60	2.60	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	205.49	4.12	2.47	2.88	1.24	7.82	4.12	3.71	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	173.28	0.00	3.33	3.33	3.33	10.00	3.33	26.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	189.60	2.52	1.68	0.84	1.40	4.75	4.19	2.80	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	180.09	2.94	2.29	1.63	0.00	5.88	1.96	3.92	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	196.29	2.52	0.84	5.03	3.36	7.55	3.36	6.71	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	182.26	2.54	0.32	0.95	0.95	4.77	2.86	3.50	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	176.28	3.74	1.70	0.00	1.36	5.77	2.72	0.68	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	177.49	0.00	0.00	2.09	4.18	2.09	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	163.22	2.86	0.00	1.15	1.15	2.86	1.15	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	100.04	0.89	0.30	2.07	0.59	4.14	1.48	1.78	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	162.64	0.00	0.00	5.08	1.69	3.39	10.16	6.78	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	188.88	2.07	1.24	2.07	1.24	5.80	6.63	2.49	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	188.94	2.76	0.00	2.76	0.92	7.36	2.76	2.30	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	131.71	5.27	0.00	0.00	0.00	10.54	10.54	15.81	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	149.92	1.54	0.00	1.54	1.15	3.46	5.00	0.38	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	136.91	1.30	0.65	1.96	0.65	3.59	1.96	2.28	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	111.70	1.34	0.67	2.68	0.00	4.68	1.34	3.34	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	113.65	2.31	0.00	2.31	0.77	5.01	3.85	1.54	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	206.09	8.90	1.71	3.42	1.37	6.50	1.71	3.77	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	104.36	2.48	0.00	12.42	2.48	19.88	2.48	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	93.43	1.42	0.47	0.47	1.42	2.36	1.42	4.25	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	96.56	3.02	0.60	0.60	2.41	3.02	2.41	1.81	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	124.12	1.02	0.00	1.02	0.51	7.12	2.54	1.53	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	129.62	1.99	0.00	1.60	1.99	5.98	2.39	0.80	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	113.47	0.99	0.00	2.47	0.99	4.44	2.47	2.96	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	160.54	1.18	0.00	1.18	1.18	8.26	7.08	0.00	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	96.85	0.58	0.58	0.00	0.00	4.08	1.17	1.17	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	94.80	0.88	0.44	0.44	0.00	3.07	1.76	1.32	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	99.18	0.85	0.00	3.39	2.54	6.78	4.24	3.39	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	109.83	2.98	0.60	0.60	0.60	5.37	4.18	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	105.78	0.49	0.49	3.88	0.49	4.85	4.37	1.46	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	67.34	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	44.08	0.00	0.00	0.42	0.00	0.83	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	59.60	1.12	0.00	0.00	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	37.74	0.32	0.00	0.63	0.00	0.00	0.00	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.63	0.00	0.00	0.00	0.00	0.42	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	156.42	1.86	0.46	1.97	0.81	2.20	2.79	1.74	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	175.89	1.86	0.68	1.86	0.68	4.05	2.70	1.52	2.53
Hep-2 cells mock treated, biol_rep3	11900-125F1	177.45	2.50	0.23	2.05	0.91	1.82	2.50	2.05	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	176.32	1.97	0.66	1.86	0.22	4.04	3.28	1.31	1.53
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	167.42	1.29	0.86	1.07	0.43	2.15	2.36	0.43	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	177.61	1.51	0.22	0.86	0.43	2.58	0.65	1.51	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	106.48	1.49	0.50	0.75	1.12	1.62	2.12	0.75	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	103.27	0.86	0.17	1.03	0.17	2.06	0.51	1.03	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	114.37	0.64	0.00	1.28	0.32	1.60	1.60	1.60	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	68.27	0.00	0.00	0.00	0.00	1.12	1.12	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.12	0.00	0.00	0.00	0.00	0.43	0.00	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	0.00	0.00	7.93	0.00	5.29	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	78.30	0.35	0.00	0.00	0.00	1.41	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	27.61	0.00	0.00	0.00	0.00	2.18	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	92.31	0.87	0.00	0.52	0.70	1.57	0.70	1.22	0.35
Hepatocyte, donor1	11523-119I2	77.48	0.00	0.00	0.00	0.00	4.84	0.00	1.21	1.21
Hepatocyte, donor2	11603-120I1	92.65	0.00	0.00	1.08	0.00	2.15	1.08	1.08	1.08
Hepatocyte, donor3	11684-122I1	83.44	0.00	0.00	1.23	0.61	1.84	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	379.21	9.14	0.65	5.22	1.96	3.92	4.57	4.57	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	134.93	1.05	1.05	1.22	0.17	1.40	0.70	0.52	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	71.48	0.14	0.27	0.27	0.41	0.14	0.69	0.41	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	178.30	3.18	6.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	297.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	134.28	8.31	1.38	1.38	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	115.12	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	0.00	0.00	0.00	0.00	0.00	0.00	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	205.03	23.07	0.00	0.00	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	91.42	13.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	185.17	12.99	0.00	0.00	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	98.37	11.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	65.35	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	169.40	9.26	0.00	0.00	0.00	1.32	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	117.52	8.87	0.00	0.00	0.00	0.00	0.00	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	123.45	8.19	0.63	0.00	0.00	0.00	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	112.90	4.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	117.58	5.17	0.65	0.00	0.65	0.65	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	117.52	6.44	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	139.34	9.78	3.26	0.81	1.63	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	58.35	4.62	0.00	0.00	0.00	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	186.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	122.96	8.84	0.00	0.80	0.00	0.80	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	94.17	2.77	0.00	0.00	0.00	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	271.45	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	94.41	7.08	0.94	0.94	0.00	0.47	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	90.70	7.26	1.81	0.91	0.00	1.81	1.81	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	147.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	90.39	8.61	1.08	0.00	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	123.23	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	197.16	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	109.68	7.01	0.64	1.28	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	143.99	5.47	1.82	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	125.68	4.28	0.00	0.00	0.00	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	165.92	16.59	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	0.00	0.00	0.00	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	100.31	6.79	0.00	0.31	0.31	1.54	1.23	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	121.17	8.78	1.76	0.00	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	132.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	155.77	7.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	79.67	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	132.92	6.48	0.00	0.00	0.00	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	95.91	1.74	0.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	67.49	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	90.60	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	90.68	2.13	0.00	0.00	1.07	1.07	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	114.99	5.54	1.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	151.03	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	101.25	9.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	99.84	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	80.36	3.17	1.06	0.00	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	53.28	0.00	0.08	0.16	0.08	0.57	0.16	0.41	0.00
Keratinocyte - epidermal, donor2	11349-117G8	29.87	0.00	0.00	0.00	0.59	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	113.49	0.19	0.28	1.23	0.57	1.89	1.99	0.95	1.23
Keratinocyte - oral, donor1	11251-116E9	95.13	0.45	0.11	0.45	0.23	0.91	0.57	0.34	0.00
Keratocytes, donor1	11527-119I6	172.26	1.03	0.00	0.34	0.34	2.06	0.34	0.00	0.69
Keratocytes, donor2	11607-120I5	59.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	36.75	0.59	0.00	0.40	0.20	0.20	0.40	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	59.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	87.38	0.00	0.00	0.00	0.00	1.08	0.00	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	86.38	1.04	0.12	0.00	0.35	0.23	0.12	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	50.76	0.50	0.00	0.00	0.00	0.40	0.10	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	65.22	0.24	0.12	0.36	0.12	0.36	0.47	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	47.16	0.56	0.00	0.56	0.00	0.56	0.28	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	81.70	0.31	0.00	1.10	0.31	1.57	1.26	0.63	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	53.77	0.54	0.00	0.00	0.54	0.00	0.00	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	40.97	0.63	0.00	0.32	0.00	1.26	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.96	0.11	0.00	0.43	0.11	0.86	0.65	0.65	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	56.63	0.00	0.00	0.41	0.00	0.82	0.82	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	29.07	0.00	0.00	0.51	0.00	0.76	0.00	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	42.65	0.14	0.00	0.42	0.56	0.42	0.56	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	44.30	0.00	0.00	0.40	0.00	0.00	0.40	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	53.51	0.00	0.00	0.39	0.39	1.16	0.39	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	21.66	0.00	0.00	0.37	0.00	0.74	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	58.54	0.00	0.00	0.70	0.00	1.05	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.08	0.00	0.00	0.24	0.00	1.19	0.24	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	38.18	0.27	0.00	0.14	0.14	0.69	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	54.82	0.62	0.00	0.31	0.62	0.31	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	33.36	0.31	0.00	0.00	0.00	0.62	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	42.82	0.00	0.18	0.00	0.00	0.91	0.37	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	44.76	0.00	0.00	0.00	0.33	0.66	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	28.70	0.00	0.00	0.59	0.00	0.88	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	28.88	0.00	0.00	0.00	0.00	1.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	50.92	0.00	0.00	0.00	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	52.78	0.27	0.00	0.00	0.27	0.54	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	49.80	0.15	0.00	1.36	0.45	0.76	0.91	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	45.10	0.00	0.00	0.52	1.04	1.04	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	60.72	0.21	0.00	0.21	0.63	2.30	1.47	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	44.66	0.30	0.00	0.45	0.30	1.20	0.60	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	45.40	0.00	0.00	0.69	0.69	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	49.11	0.19	0.00	0.00	0.19	0.94	0.19	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.54	0.11	0.11	0.11	0.32	0.74	0.64	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	60.57	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	45.65	0.00	0.00	0.33	0.00	1.65	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	31.34	0.00	0.00	0.25	0.00	0.37	0.12	0.25	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.08	0.00	0.00	0.74	0.37	0.37	0.37	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.99	0.00	0.25	0.49	0.25	0.49	0.00	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.47	0.00	0.00	0.00	0.27	0.69	0.41	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	58.54	0.00	0.00	0.96	0.00	0.96	0.64	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	70.60	0.30	0.00	0.61	0.30	0.91	1.22	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	56.13	0.42	0.00	0.70	0.00	1.68	0.28	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	56.18	0.00	0.00	0.00	0.00	0.36	1.07	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	31.03	0.00	0.00	0.00	0.00	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	27.08	0.16	0.00	0.00	0.16	0.31	0.00	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	49.78	0.36	0.00	0.36	0.00	0.72	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	53.25	0.00	0.00	0.00	0.33	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	21.42	0.00	0.00	0.24	0.47	0.00	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	69.05	0.50	0.00	0.62	0.00	0.62	0.50	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.10	0.00	0.00	0.26	0.51	0.77	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	35.80	0.00	0.00	0.00	0.00	0.90	0.90	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	120.10	0.00	2.27	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	142.69	0.77	0.77	1.53	1.53	1.53	2.30	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	129.89	0.00	0.00	0.74	0.74	0.74	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	166.29	6.35	0.00	2.54	0.42	4.23	2.12	2.54	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	142.07	0.70	0.00	1.41	1.41	0.70	1.41	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	118.61	2.80	0.00	0.93	1.87	0.93	1.87	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	134.49	3.61	0.52	3.61	1.03	6.18	2.58	1.55	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	117.76	1.19	0.00	1.19	1.19	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	126.44	1.58	0.23	0.45	0.68	0.90	0.45	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	136.11	2.04	0.58	2.04	0.00	7.56	3.78	2.04	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	135.95	1.35	0.45	4.05	1.80	11.70	3.15	1.35	7.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	148.90	1.22	0.68	0.81	0.41	1.90	0.41	0.27	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	150.98	3.59	1.03	2.57	2.05	5.14	1.54	6.68	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	140.08	1.06	0.35	1.06	0.35	2.12	0.35	2.12	2.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	109.27	1.33	0.00	0.67	0.00	2.00	0.67	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	173.19	3.57	0.00	2.04	1.53	11.72	4.08	5.60	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	175.29	1.33	0.00	1.87	1.07	3.74	2.13	1.33	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	184.79	2.46	0.38	1.70	0.57	2.65	1.70	2.08	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	167.50	3.68	0.61	3.68	1.23	4.91	2.45	3.07	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	173.69	2.45	0.82	3.26	0.82	8.97	4.89	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	153.48	0.83	0.21	1.87	0.83	4.37	2.92	2.08	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	161.43	2.52	0.00	3.08	1.68	8.97	3.92	7.01	4.20
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	153.52	0.00	0.00	0.00	0.00	1.03	3.09	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	164.89	2.32	0.00	2.61	0.87	4.94	3.77	3.19	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	156.04	2.09	0.30	0.90	0.60	6.88	1.79	2.39	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	161.00	1.11	0.00	0.00	0.55	6.09	2.21	2.21	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	179.22	3.53	0.00	2.47	1.41	2.12	2.12	3.53	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	154.52	3.69	1.11	2.21	0.37	6.27	4.43	2.95	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	154.27	0.00	0.00	0.00	0.00	3.45	0.00	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	167.32	3.84	0.38	1.15	0.38	3.07	3.45	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	143.23	2.83	0.00	2.83	2.26	8.49	3.40	2.83	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	152.61	4.10	0.00	0.82	0.00	4.92	0.82	1.64	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	180.30	2.26	0.90	0.45	0.00	2.71	1.36	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	157.27	2.15	0.00	1.44	2.15	7.90	2.15	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	153.12	1.49	0.00	0.00	1.49	6.72	1.49	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	159.04	4.83	0.00	1.86	0.00	4.46	3.34	3.34	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	148.61	1.72	0.00	1.29	1.29	6.46	2.15	3.88	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	158.42	3.43	0.00	1.71	0.00	2.57	0.86	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	175.92	2.67	0.00	1.67	1.67	5.00	2.33	3.00	3.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	161.69	5.43	0.60	1.21	0.60	4.83	1.81	1.21	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	156.42	1.42	0.00	2.84	0.71	2.13	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	165.67	2.06	0.69	2.06	0.69	5.16	3.78	1.72	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	156.19	2.68	0.00	1.61	2.68	6.44	4.29	5.90	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	173.73	3.37	0.00	3.37	0.00	2.02	2.02	2.69	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	192.24	2.59	0.00	3.33	2.59	8.52	3.70	2.22	5.56
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	154.67	2.33	0.00	1.16	0.00	1.16	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	159.72	4.23	0.00	0.00	1.06	2.12	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	184.87	2.80	0.00	1.60	0.00	6.00	5.20	4.00	4.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	183.17	5.81	0.73	3.63	0.00	2.18	0.00	3.63	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	221.52	7.67	0.77	1.53	0.00	1.53	0.77	1.53	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	193.36	5.43	1.48	0.99	1.97	2.96	3.95	1.97	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	163.72	4.70	0.00	0.94	0.94	0.94	0.00	3.76	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	222.25	4.53	0.50	1.01	0.00	1.01	2.01	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	180.25	2.70	0.00	0.90	1.35	3.15	3.15	3.15	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	184.16	5.16	0.00	0.00	0.00	8.61	1.72	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	183.48	3.56	0.89	3.12	0.89	3.56	2.23	4.01	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	186.91	1.56	1.17	1.17	1.56	4.69	1.96	2.74	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	164.93	3.96	0.66	0.66	0.66	6.60	1.98	6.60	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	196.15	1.56	0.52	0.52	0.52	3.11	3.11	3.63	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	205.22	1.75	1.31	1.75	0.44	5.25	2.63	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	177.79	1.68	0.00	1.68	0.00	7.83	2.24	1.12	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	194.76	1.77	0.44	1.77	0.88	5.30	2.21	2.65	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	194.79	1.54	0.39	0.77	1.16	4.24	3.47	2.31	3.86
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	165.07	2.03	0.00	1.52	3.04	8.10	5.06	2.53	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	191.77	0.96	0.48	1.44	1.44	4.33	1.44	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	187.64	1.99	1.19	0.40	1.19	4.37	1.99	3.18	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	179.86	0.61	0.00	1.22	1.22	4.86	4.25	2.43	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	100.30	2.08	0.00	0.69	0.00	0.69	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	198.74	0.76	0.38	1.90	0.76	5.70	1.90	2.66	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	183.84	2.07	0.00	2.07	1.03	12.91	3.10	4.65	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	108.23	1.81	0.60	1.21	0.00	3.63	1.81	1.21	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	190.77	2.22	0.00	2.22	0.32	6.65	3.49	1.58	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	189.25	3.73	0.00	0.00	0.53	3.73	0.00	2.13	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	118.96	4.60	0.00	0.57	0.00	3.45	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	176.90	2.57	0.51	1.54	0.51	7.71	2.06	3.60	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	166.94	0.71	0.71	2.12	0.00	5.66	0.00	4.24	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	129.95	1.70	0.00	1.13	0.57	2.27	2.84	1.13	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	183.05	2.08	0.42	0.83	0.42	4.58	1.25	2.50	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	166.00	0.78	0.00	0.78	0.78	11.75	0.78	1.57	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	126.52	4.59	0.42	1.25	0.42	1.67	0.42	1.25	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	177.03	1.39	0.00	0.46	0.93	4.18	2.32	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	163.92	1.34	0.00	1.34	0.67	6.02	3.35	3.35	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	151.30	1.60	0.53	2.14	0.00	4.81	1.60	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	196.39	4.04	0.40	2.42	1.21	6.47	2.42	3.23	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	189.06	5.51	3.67	0.00	0.92	1.84	0.92	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	136.92	4.45	0.00	0.00	0.00	4.45	1.78	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	209.71	1.14	0.57	1.14	0.57	1.71	1.71	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	233.14	3.83	0.00	3.83	0.00	4.60	1.53	3.07	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	152.66	1.64	0.55	2.19	1.09	7.11	2.19	2.74	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	242.32	1.78	0.45	2.67	0.89	6.68	4.45	3.56	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	229.28	0.78	0.52	0.52	0.52	2.60	0.52	1.30	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	194.29	3.32	0.00	1.99	1.33	4.64	4.64	1.33	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	212.02	0.00	0.00	4.16	0.00	6.24	2.08	8.31	12.47
Macrophage - monocyte derived, donor1	11232-116C8	60.85	0.23	0.00	0.00	0.68	0.00	0.23	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	57.25	0.00	0.00	0.00	0.18	0.00	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	77.21	0.39	0.00	0.52	0.26	0.66	0.79	0.26	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	74.34	1.59	0.00	0.00	0.00	0.53	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	66.23	0.48	0.00	0.16	0.16	1.11	0.00	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	93.54	0.28	0.14	0.14	0.14	1.11	0.56	0.97	0.42
Mammary Epithelial Cell, donor1	11273-116H4	69.85	0.10	0.00	0.10	0.20	0.90	0.40	0.30	0.10
Mammary Epithelial Cell, donor2	11350-117G9	78.76	0.87	0.00	0.29	0.29	1.16	0.00	0.58	0.58
Mammary Epithelial Cell, donor3	11422-118F9	53.88	0.50	0.00	0.75	0.00	1.50	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	234.57	0.00	0.00	0.00	3.39	1.36	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	98.30	0.11	0.00	0.22	0.22	1.51	0.11	0.22	0.54
Mast cell, donor2	11565-120D8	95.99	0.59	0.00	0.00	0.59	2.08	0.30	0.59	0.89
Mast cell, donor3	11566-120D9	155.56	0.45	0.00	0.68	0.00	3.15	0.00	2.03	0.45
Mast cell, donor4	11567-120E1	92.37	0.18	0.18	0.00	0.18	1.95	0.18	0.35	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	107.23	0.22	0.00	0.44	0.44	2.22	0.55	1.00	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	109.73	1.75	0.00	0.00	1.17	5.25	0.58	2.92	0.58
Mast cell, expanded, donor5	11939-126A4	110.13	0.46	0.00	0.80	0.69	2.98	1.61	1.15	0.80
Mast cell, expanded, donor8	11941-126A6	101.93	0.33	0.00	0.84	0.17	4.02	0.67	1.17	0.33
Melanocyte - dark, donor1	11502-119F8	95.62	0.40	0.00	0.40	0.00	0.50	0.20	0.40	0.70
Melanocyte - dark, donor2	11582-120F7	63.33	0.69	0.00	0.00	0.00	0.69	0.35	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	91.78	0.36	0.00	0.22	0.22	0.36	0.14	0.51	0.29
Melanocyte - light, donor1	11274-116H5	34.09	0.00	0.00	0.71	0.24	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	30.71	0.00	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	39.03	0.87	0.00	1.73	0.87	1.73	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	103.81	0.52	0.10	0.42	0.10	1.67	2.08	0.62	1.46
Melanocyte, donor2 (MC+2)	12739-135I3	71.00	0.27	0.00	0.54	0.54	1.34	1.08	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	58.93	0.27	0.00	0.27	0.00	1.07	0.00	1.07	0.27
Meningeal Cells, donor1	11493-119E8	169.47	2.36	0.12	0.12	0.00	1.36	0.25	0.87	0.37
Meningeal Cells, donor2	11573-120E7	119.28	0.44	0.00	1.32	0.44	0.44	0.44	0.00	0.88
Meningeal Cells, donor3	11654-122E7	165.77	0.82	0.08	0.41	0.57	0.90	0.98	0.33	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	113.78	0.57	0.00	0.86	0.29	0.57	0.29	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	51.12	0.40	0.10	0.10	0.10	0.40	0.50	0.10	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	103.34	0.00	0.00	0.72	0.00	0.72	1.44	1.44	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	54.21	0.21	0.00	0.21	0.00	1.91	0.21	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	70.87	1.51	0.00	1.01	0.00	2.01	0.50	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	94.71	1.32	0.00	0.44	0.22	0.00	0.44	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	101.55	0.73	0.00	0.00	0.73	0.00	1.46	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	82.25	0.61	0.41	0.00	0.41	1.23	0.00	0.20	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	46.54	0.00	0.00	0.28	0.00	0.42	0.42	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	17.84	0.00	0.00	0.00	0.00	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	53.42	0.00	0.00	0.13	0.26	0.26	0.13	0.26	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.35	0.00	0.00	0.30	0.00	0.30	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	74.93	0.00	0.00	0.00	0.00	0.64	0.64	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	150.99	1.06	0.71	0.35	0.00	1.06	1.06	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	59.10	0.31	0.00	0.00	0.00	0.31	0.63	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	120.46	0.73	0.00	0.00	2.18	1.45	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	51.44	0.27	0.00	0.00	0.53	1.06	0.53	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	37.03	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	54.92	0.22	0.00	0.65	0.29	0.72	0.36	0.51	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	64.52	0.00	0.00	0.25	0.00	0.25	0.25	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	65.37	0.00	0.00	0.00	0.29	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	53.31	0.31	0.00	0.00	0.31	0.31	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	47.92	0.21	0.00	0.21	0.00	0.83	0.21	0.62	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	57.81	0.50	0.00	0.25	0.00	0.50	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	56.32	0.00	0.00	0.00	0.00	0.00	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	55.07	0.20	0.00	0.20	0.20	0.81	0.81	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	49.89	0.00	0.00	1.19	0.40	0.40	0.00	0.00	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	34.51	0.00	0.00	0.00	0.00	0.00	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	52.05	0.76	0.00	0.00	0.00	0.38	0.00	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	34.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	43.08	0.21	0.00	0.00	0.00	0.85	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	41.44	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	33.08	0.30	0.00	0.60	0.00	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	41.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	43.16	0.00	0.00	0.50	0.25	0.50	1.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	43.97	0.00	0.00	0.48	0.48	0.24	0.00	0.95	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	45.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	30.16	0.00	0.00	0.46	0.23	1.15	0.46	0.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	46.27	0.00	0.21	0.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	38.52	0.41	0.00	0.00	0.00	0.20	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	30.04	0.00	0.21	0.43	0.00	0.21	0.21	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	39.57	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	31.98	0.22	0.00	0.22	0.00	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	29.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	28.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	28.54	0.00	0.00	0.00	0.27	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	31.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	41.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	30.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	37.62	0.00	0.00	0.00	0.00	1.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	0.00	0.00	0.00	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	36.04	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	34.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	40.73	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	40.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	46.36	0.25	0.00	0.25	0.50	1.24	0.00	0.99	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	35.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	50.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	36.58	0.00	0.00	0.00	0.00	0.68	0.68	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	34.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	39.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	39.00	0.00	0.00	0.28	0.28	0.56	0.00	0.84	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	51.95	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.13	0.00	0.00	0.00	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	32.28	0.00	0.00	0.00	0.00	0.60	0.30	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	46.75	0.00	0.00	0.00	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	27.71	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	38.70	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	32.75	0.28	0.00	0.14	0.00	0.00	0.28	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	34.99	0.00	0.00	0.00	0.00	0.26	0.78	0.52	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	48.05	0.43	0.00	0.00	0.00	0.00	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	35.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.82	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	42.80	0.00	0.00	0.00	0.00	0.00	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	32.49	0.00	0.00	0.00	0.00	0.71	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	33.13	0.00	0.00	0.00	0.00	0.64	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	47.32	0.22	0.00	0.44	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	42.09	0.00	0.00	0.00	0.00	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	43.47	0.00	0.00	0.28	0.00	0.85	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	44.00	0.00	0.00	0.74	0.00	0.49	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	38.45	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	40.87	0.00	0.00	0.88	0.00	0.29	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	49.30	0.00	0.00	0.00	0.00	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	34.62	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	41.99	0.30	0.00	0.89	0.30	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00	3.77	0.00	3.77	3.77	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	1.78	0.00	0.00	0.00	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	52.90	0.33	0.00	0.66	0.66	1.31	0.33	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	48.39	1.05	0.00	4.21	0.00	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	57.13	0.40	0.00	0.20	0.20	0.99	0.59	0.40	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	68.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	60.46	0.00	0.00	1.13	0.00	1.88	0.38	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.69	0.00	0.00	0.80	0.00	0.80	0.27	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	56.21	0.00	0.00	0.57	0.11	0.45	0.45	0.57	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	0.00	0.00	0.00	0.00	2.21	0.74	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	45.80	0.73	0.00	0.73	0.00	0.00	1.10	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	59.11	0.00	0.00	0.00	1.56	7.78	0.00	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	63.06	0.00	0.00	0.00	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	37.37	0.00	0.00	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	47.65	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	39.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	0.00	0.00	0.00	0.00	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	40.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	262.67	22.84	0.00	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	166.38	6.52	0.00	0.00	3.26	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	0.00	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	0.00	0.00	0.00	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	77.77	0.43	0.00	0.43	0.00	1.29	0.65	0.00	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	54.35	0.52	0.00	0.52	0.52	1.57	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	66.08	0.67	0.00	0.00	0.00	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	63.44	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	122.83	1.90	0.00	0.57	0.00	2.28	0.76	0.57	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	126.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	55.08	0.00	0.00	0.68	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	90.04	0.00	0.00	0.00	0.00	3.68	0.00	0.00	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	38.09	0.00	0.00	0.42	0.00	0.00	0.00	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	84.14	0.70	0.00	0.00	0.00	0.70	0.46	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	48.37	0.81	0.00	0.00	0.00	0.27	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	67.91	0.63	0.00	0.00	0.00	0.63	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	233.83	11.13	0.00	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.18	0.00	0.00	0.50	0.50	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	41.14	0.27	0.00	0.27	0.00	0.27	0.54	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	45.79	0.00	0.00	0.45	0.23	0.91	0.23	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	50.95	0.16	0.00	0.00	0.33	0.33	0.16	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	55.59	0.00	0.00	0.18	0.36	0.55	0.36	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	40.31	0.53	0.00	0.00	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	34.22	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	49.23	0.00	0.00	0.66	0.33	2.63	0.66	1.31	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	43.26	0.00	0.00	0.00	0.33	0.49	0.16	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	49.39	0.00	0.00	0.00	0.00	0.35	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	45.01	0.00	0.00	0.00	0.00	0.70	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	44.59	0.00	0.00	0.00	0.92	1.38	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	56.24	0.00	0.00	0.00	0.00	0.96	0.64	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	47.94	0.34	0.00	1.72	0.34	3.45	0.69	1.38	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	98.61	0.00	0.00	0.00	2.53	2.53	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	55.03	0.00	0.00	0.22	0.22	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	60.12	0.00	0.00	0.85	0.85	2.54	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	60.05	0.00	0.00	0.24	0.24	0.71	0.24	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	53.66	0.86	0.00	0.86	0.00	0.86	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	0.00	0.00	0.00	0.00	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	46.32	0.33	0.00	0.00	0.00	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	39.68	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	54.76	0.00	0.00	0.00	0.40	1.19	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	59.43	0.00	0.00	0.00	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	62.81	0.38	0.00	0.38	0.38	0.76	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	43.02	0.33	0.00	0.00	0.33	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	46.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	41.16	0.00	0.00	0.00	0.45	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	46.74	0.00	0.00	0.00	0.88	1.76	0.88	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	56.51	0.00	0.00	0.00	0.00	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	56.05	0.50	0.00	0.00	0.00	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	40.96	1.15	0.00	0.00	0.38	1.15	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	76.82	0.30	0.00	0.30	0.00	0.60	0.91	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.07	0.22	0.00	0.22	0.44	0.00	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	48.11	0.00	0.00	0.68	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	127.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	65.24	0.00	0.00	1.22	0.00	2.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	49.10	0.63	0.31	0.00	0.00	0.31	0.63	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	42.67	0.00	0.00	0.00	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	44.30	0.00	0.00	0.79	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	39.68	0.00	0.00	0.00	2.27	3.40	0.00	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	131.51	0.00	0.00	0.00	0.00	5.06	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	81.62	0.25	0.00	0.37	0.50	1.24	0.87	0.50	0.75
Myoblast, donor2	11322-117D8	108.36	0.38	0.00	1.92	0.58	1.34	0.96	0.38	0.96
Myoblast, donor3	11398-118D3	100.22	0.34	0.34	0.50	0.34	0.67	0.00	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	195.70	1.75	1.31	1.61	0.44	2.48	0.88	1.75	1.02
Natural Killer Cells, donor1	11230-116C6	93.79	2.15	0.00	0.62	0.31	0.92	0.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	87.75	1.81	0.30	0.00	0.90	1.51	0.30	0.60	1.51
Natural Killer Cells, donor3	11387-118C1	94.79	2.21	0.18	0.55	0.74	0.92	0.74	0.92	0.37
Neural stem cells, donor1	11275-116H6	114.69	2.54	1.09	0.00	0.73	1.09	0.00	1.09	0.00
Neural stem cells, donor2	11352-117H2	152.13	0.00	0.00	1.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	128.58	2.28	0.00	2.28	0.00	1.14	2.28	0.00	0.00
Neurons, donor2	11574-120E8	132.10	1.54	0.00	0.22	0.22	1.10	1.76	0.88	0.66
Neurons, donor3	11655-122E8	142.23	4.11	0.00	1.64	0.00	3.29	3.29	3.29	0.82
Neutrophils, donor1	11233-116C9	73.31	0.00	0.00	0.00	0.00	1.86	0.93	0.93	0.93
Neutrophils, donor2	11314-117C9	69.57	0.00	0.00	5.80	0.00	8.70	0.00	5.80	5.80
Neutrophils, donor3	11390-118C4	81.24	0.00	0.00	1.22	0.61	0.61	1.22	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	64.35	0.12	0.00	0.24	0.24	0.24	0.59	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	35.17	0.00	0.00	0.65	0.00	0.98	0.00	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	50.14	0.60	0.00	0.20	0.20	0.40	0.80	0.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	49.00	0.41	0.00	0.14	0.28	1.10	0.41	0.41	0.41
Olfactory epithelial cells, donor2	11934-125I8	75.56	0.14	0.14	0.29	0.72	2.32	2.61	1.01	0.58
Olfactory epithelial cells, donor3	11935-125I9	54.82	0.11	0.00	0.45	0.34	0.11	0.23	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	62.92	0.29	0.29	0.00	0.29	0.39	0.19	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	92.68	0.00	0.00	0.00	0.00	0.60	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	32.54	0.43	0.00	0.21	0.21	1.06	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	14.86	0.00	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	39.73	0.62	0.00	0.00	0.62	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	57.26	0.59	0.59	0.00	0.00	0.20	0.39	0.00	0.20
Osteoblast, donor2	11354-117H4	150.30	1.40	0.00	0.00	1.40	2.81	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	120.68	1.07	0.00	0.53	0.36	0.53	0.71	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	114.31	0.67	0.17	0.67	0.67	2.53	1.26	0.76	0.67
Pericytes, donor1	11491-119E6	16.58	0.33	0.00	0.00	0.00	0.11	0.11	0.00	0.11
Pericytes, donor2	11571-120E5	23.99	0.00	0.00	0.45	0.00	0.23	0.23	0.23	0.00
Pericytes, donor3	11652-122E5	64.70	0.41	0.00	0.41	0.00	0.20	0.41	1.02	0.61
Perineurial Cells, donor1	11499-119F5	95.96	0.45	0.11	0.23	0.11	0.45	0.23	0.11	0.23
Perineurial Cells, donor2	11579-120F4	86.40	0.46	0.00	0.37	0.09	0.74	0.28	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	81.28	0.32	0.00	0.32	0.32	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	69.05	0.49	0.00	0.49	0.73	0.73	3.43	0.98	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	71.57	0.78	0.00	0.00	0.52	1.04	0.39	0.65	0.52
Placental Epithelial Cells, donor1	11278-116H9	33.72	0.00	0.00	0.48	0.00	0.48	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	41.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	45.55	0.39	0.00	0.20	0.20	1.18	0.79	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	31.33	0.00	0.00	0.00	0.00	0.63	0.63	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	39.39	0.19	0.19	0.19	0.00	0.94	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	69.44	0.26	0.00	0.52	0.13	0.13	0.00	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	49.98	0.23	0.00	0.23	0.23	1.13	0.45	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	47.63	0.11	0.00	0.53	0.64	0.64	0.11	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	48.45	0.87	0.00	0.00	0.44	2.18	0.44	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	62.03	0.14	0.00	0.43	0.29	2.58	0.14	0.43	0.72
Preadipocyte - perirenal, donor1	11469-119C2	31.50	0.00	0.00	0.00	0.00	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	56.82	0.00	0.61	0.00	0.31	0.92	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	171.06	2.83	0.18	2.12	0.53	1.06	2.48	1.42	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	90.93	1.36	0.00	0.68	0.51	2.21	0.34	0.85	0.34
Preadipocyte - visceral, donor1	11280-116I2	131.52	1.68	0.37	0.47	0.19	1.02	0.28	0.37	0.19
Preadipocyte - visceral, donor2	11357-117H7	97.10	1.38	0.00	0.92	0.46	3.22	1.38	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	101.15	0.94	0.21	0.73	0.42	1.46	1.15	0.52	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	146.18	1.96	1.06	1.36	0.30	6.49	1.66	1.36	1.51
Prostate Epithelial Cells, donor2	11331-117E8	58.36	0.54	0.00	0.54	0.00	1.76	0.81	1.08	0.41
Prostate Epithelial Cells, donor3	11404-118D9	39.13	0.06	0.06	0.24	0.18	1.29	0.55	0.37	0.18
Prostate Stromal Cells, donor1	11254-116F3	130.07	2.51	0.11	1.14	0.23	2.96	0.91	1.03	0.68
Prostate Stromal Cells, donor2	11332-117E9	129.45	1.43	0.00	1.97	0.54	2.87	2.15	1.97	0.90
Prostate Stromal Cells, donor3	11405-118E1	59.02	0.10	0.10	1.04	0.73	1.56	1.36	0.63	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	45.26	0.36	0.00	0.00	0.00	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	51.50	0.55	0.07	0.35	0.07	0.69	0.49	0.42	0.21
Renal Epithelial Cells, donor1	11517-119H5	44.13	1.52	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	63.31	0.71	0.00	1.42	0.00	0.71	1.42	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	74.00	0.85	0.00	0.11	0.21	0.85	0.11	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	45.62	0.00	0.00	0.68	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	67.79	0.00	0.00	0.27	0.54	0.27	0.54	0.40	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	113.45	0.89	0.00	1.11	0.67	2.22	1.78	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	18.63	0.00	0.00	0.00	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	60.96	0.44	0.00	0.22	0.22	0.44	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	72.73	1.25	0.00	0.00	0.00	1.88	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	29.68	0.00	0.00	0.00	0.00	0.55	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	121.86	1.61	0.27	0.27	0.00	1.07	0.27	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	57.35	0.00	0.42	0.42	0.42	0.00	1.27	0.42	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	92.57	0.39	0.58	0.58	0.39	1.16	0.39	1.16	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	88.67	1.56	0.00	0.26	0.00	0.26	0.78	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	70.49	0.00	0.00	0.00	0.00	1.14	0.28	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	61.75	1.03	1.03	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	58.71	1.00	0.25	0.00	0.75	1.00	0.25	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	83.39	0.67	0.00	0.27	0.27	0.94	0.53	0.00	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	98.27	3.57	0.00	0.00	0.00	0.89	0.00	2.68	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	139.24	3.30	0.00	0.00	1.65	6.05	2.75	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	114.85	4.64	0.00	0.00	0.00	1.16	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	157.72	4.03	0.26	0.65	0.00	1.43	0.26	0.65	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	169.51	4.07	0.30	0.89	0.50	1.89	0.79	0.70	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	217.95	6.58	0.22	1.12	0.56	2.01	1.12	1.45	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	231.34	6.95	0.12	2.11	0.37	2.48	2.85	1.24	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	177.61	3.03	0.12	1.52	0.58	2.21	2.91	1.63	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	203.16	6.70	0.46	1.16	0.46	3.47	2.54	1.85	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	126.23	4.24	0.00	1.23	0.14	1.92	1.10	1.23	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	173.66	3.93	0.45	1.36	0.61	1.97	1.97	1.66	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	195.32	5.55	0.54	0.72	0.36	0.90	1.97	0.36	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	152.92	4.88	0.43	2.44	0.29	1.72	0.57	0.57	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	162.47	3.76	0.21	1.40	0.21	1.18	3.00	0.64	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	186.09	5.31	0.22	2.21	0.89	1.33	2.43	0.44	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	134.21	5.35	0.00	0.96	0.38	1.91	0.38	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	169.09	3.35	0.09	1.02	0.19	1.49	1.21	0.28	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	232.82	8.46	0.38	0.94	0.38	2.82	0.56	1.32	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	149.56	4.38	0.27	0.40	0.40	1.46	0.27	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	180.18	3.41	0.68	0.58	0.00	0.97	1.36	0.68	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	182.94	4.20	0.95	2.48	0.57	1.91	1.72	0.76	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	149.40	4.70	0.43	1.17	0.43	1.39	0.75	1.17	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	153.05	4.48	0.00	2.52	0.84	1.96	2.80	0.84	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	180.13	3.25	0.85	1.03	0.68	2.39	1.71	2.05	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	142.95	5.29	0.73	0.91	0.00	0.91	0.73	1.28	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	149.49	3.92	0.25	1.23	0.25	1.96	2.82	0.98	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	220.15	4.84	0.00	1.07	0.54	1.61	1.75	0.81	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	144.83	6.13	0.24	0.94	0.24	2.36	0.94	1.89	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	164.68	6.35	0.20	1.39	0.60	0.99	0.79	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	193.16	5.38	0.47	3.74	0.47	3.04	1.64	1.64	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	163.81	7.05	0.21	1.87	0.41	2.49	1.04	1.24	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	164.80	5.09	0.44	1.55	1.99	3.76	3.10	3.98	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	182.56	4.18	0.00	0.42	0.42	1.88	1.46	1.67	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	167.96	4.85	0.54	1.35	0.54	1.62	0.54	1.62	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	195.16	2.21	0.17	0.17	0.00	1.19	0.17	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	202.82	3.66	0.00	0.77	0.19	2.89	1.54	0.77	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	164.54	4.47	0.17	1.72	0.34	3.44	1.72	1.55	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	177.50	2.88	0.00	0.27	0.55	0.82	0.69	0.69	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	194.21	4.10	0.00	2.96	1.48	3.12	2.46	0.99	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	152.19	1.87	0.17	1.19	0.51	1.70	1.36	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	190.13	4.29	0.15	1.18	0.44	1.18	1.33	0.74	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	170.86	1.60	0.00	0.27	0.00	1.60	0.53	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	139.93	3.73	0.14	0.83	0.14	1.94	1.11	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	167.62	3.33	0.24	0.48	1.43	2.14	1.43	0.24	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	181.39	2.62	1.01	0.60	0.20	1.61	0.40	1.61	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	131.47	3.58	0.09	1.60	0.66	3.01	1.04	1.32	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	154.42	2.10	0.35	1.75	1.05	3.14	2.10	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	135.39	1.51	0.30	0.00	0.00	2.12	1.21	0.91	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	144.42	4.65	0.00	2.33	1.10	2.57	0.73	1.96	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	281.06	10.04	0.58	1.31	1.02	2.04	0.87	1.46	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	169.14	3.04	0.00	3.04	0.00	2.43	4.26	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	149.80	4.22	0.00	1.81	0.60	2.41	0.90	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	153.13	3.62	0.23	1.13	0.90	3.85	0.68	0.68	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	187.21	3.29	0.60	1.50	0.60	3.29	4.49	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	150.54	4.01	0.00	0.94	2.01	6.26	1.53	0.83	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	185.27	3.42	0.21	1.07	18.36	5.34	0.64	2.13	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	189.31	3.61	1.80	1.20	3.00	2.40	1.80	1.80	1.80
Schwann Cells, donor1	11498-119F4	54.35	0.19	0.00	0.00	0.38	0.56	0.38	0.00	0.38
Schwann Cells, donor2	11578-120F3	102.07	0.00	0.00	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	83.91	0.66	0.22	0.44	0.66	1.31	1.31	0.66	0.66
Sebocyte, donor1	11220-116B5	96.41	0.00	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	64.80	0.00	0.00	0.00	0.92	0.92	0.92	1.38	0.00
Sebocyte, donor3	11378-118B1	34.21	0.21	0.00	0.41	0.21	0.00	0.41	0.00	0.21
Sertoli Cells, donor1	11255-116F4	82.83	0.00	0.00	0.00	0.00	0.00	0.00	1.66	3.31
Sertoli Cells, donor2	11333-117F1	59.31	0.00	0.00	2.82	0.00	0.00	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	72.05	0.97	0.09	0.09	0.09	1.32	0.35	0.53	0.26
Skeletal Muscle Cells, donor2	11358-117H8	14.46	0.00	0.00	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	107.01	2.51	0.00	0.00	0.00	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	143.90	1.10	0.00	1.73	0.63	2.67	1.57	0.94	0.47
Skeletal Muscle Cells, donor5	11455-119A6	136.31	1.19	0.30	2.08	0.74	1.04	2.23	0.74	0.59
Skeletal Muscle Cells, donor6	11459-119B1	178.53	1.08	0.31	1.23	0.00	2.00	2.92	1.23	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	118.19	0.50	0.00	0.88	0.50	1.64	0.63	0.50	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	115.86	0.86	0.14	0.86	0.71	2.00	2.00	1.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	194.35	0.89	0.20	1.49	0.79	3.37	1.88	1.39	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	96.05	0.67	0.08	0.25	0.34	0.67	0.34	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	91.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	44.99	0.69	0.00	0.28	0.14	0.00	0.41	0.14	0.14
Skin - palm, donor1	10286-104F7	115.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	40.94	0.29	0.29	0.00	0.58	1.01	0.43	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	295.26	0.00	0.82	1.64	0.00	4.91	1.64	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	47.91	0.26	0.26	0.13	0.00	0.39	0.39	1.04	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	60.33	0.42	0.00	0.42	0.28	1.39	0.56	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	67.23	0.00	0.00	0.42	0.42	0.56	0.56	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	342.75	1.27	0.42	1.06	0.42	1.48	0.63	0.85	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	63.41	0.07	0.00	0.30	0.30	0.90	0.22	0.30	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	42.58	0.00	0.00	0.62	0.00	1.54	0.31	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	61.36	0.22	0.00	0.44	0.22	0.67	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	61.72	0.59	0.00	0.00	0.59	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	62.10	0.22	0.00	0.22	0.00	0.88	0.22	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	36.62	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	55.62	0.77	0.00	0.00	0.00	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	48.04	1.00	0.00	0.00	0.00	1.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	43.78	0.27	0.00	0.00	0.13	0.53	0.13	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	69.16	0.00	0.44	0.66	0.66	1.33	0.44	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	72.59	0.00	0.00	0.26	0.26	1.15	0.51	0.51	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	81.07	0.33	0.00	0.65	0.33	0.00	0.00	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	71.47	0.30	0.00	0.30	0.00	0.30	0.59	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	59.37	0.28	0.00	0.43	0.28	0.28	0.28	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	41.64	0.00	0.00	0.00	0.16	0.00	0.16	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	40.49	0.00	0.00	0.00	0.00	0.61	0.61	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	54.81	1.01	0.00	0.00	0.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	201.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	35.76	0.48	0.00	0.48	0.48	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	68.43	0.59	0.00	0.29	0.00	1.03	0.74	0.00	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	71.24	0.43	0.22	0.43	0.43	0.86	2.80	1.72	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	102.96	0.52	0.10	1.26	0.52	1.68	1.05	0.84	1.26
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	41.30	0.31	0.00	0.31	0.31	0.46	0.15	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	36.65	0.00	0.00	0.00	1.08	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	48.71	0.00	0.00	0.30	0.00	0.00	0.30	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.09	0.68	0.00	0.00	0.34	0.34	0.34	1.02	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	67.69	0.31	0.00	0.55	0.16	0.31	0.39	0.31	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	71.86	0.50	0.10	0.70	0.30	1.61	0.20	0.30	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	60.98	0.23	0.00	0.91	0.23	0.68	0.68	0.46	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	36.23	0.00	0.00	0.00	0.00	0.00	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	244.53	2.91	0.53	1.06	1.06	1.59	0.26	1.85	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	91.21	1.46	0.13	0.93	0.67	1.46	0.27	0.53	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	92.16	0.50	0.00	0.63	0.38	2.00	1.25	0.88	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.05	0.25	0.00	0.00	0.00	0.51	0.00	1.27	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	78.55	0.60	0.00	0.00	0.00	0.75	0.45	0.30	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	49.51	0.00	0.00	0.75	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	223.55	0.00	0.00	1.29	1.29	2.58	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	47.44	0.00	0.00	0.00	0.00	0.00	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	58.06	0.50	0.00	0.50	0.50	1.01	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	24.13	0.00	0.00	0.00	0.00	0.63	0.94	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	30.68	0.00	0.00	0.00	0.00	0.59	0.00	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	138.21	0.75	0.00	0.00	0.00	0.75	0.17	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	43.91	0.47	0.00	0.00	0.00	0.00	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	39.15	0.14	0.00	0.00	0.43	0.00	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	64.76	1.02	0.00	0.51	0.25	1.02	1.02	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	47.76	0.38	0.00	0.56	0.00	0.19	0.38	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	126.61	0.28	0.28	0.56	0.14	0.98	0.28	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	58.32	0.34	0.00	0.17	0.17	0.50	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	40.37	0.00	0.00	0.00	0.49	0.24	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	77.77	0.44	0.00	0.88	0.22	2.65	0.44	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	61.44	1.17	0.00	0.59	0.59	0.29	1.17	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	46.26	0.00	0.00	0.19	0.19	1.17	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	33.32	0.26	0.00	0.00	0.53	0.53	0.79	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.75	0.00	0.00	1.12	0.74	2.60	0.00	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	37.73	0.36	0.00	0.72	0.00	1.08	0.36	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	52.24	0.57	0.00	0.57	0.85	1.42	0.28	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	94.92	1.58	0.00	0.39	0.00	1.58	0.79	1.97	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	36.82	0.25	0.00	0.00	0.25	2.54	0.25	0.76	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	42.73	0.00	0.00	0.00	0.40	1.60	0.40	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	43.05	0.00	0.42	0.42	0.00	1.67	1.67	1.67	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	44.46	0.00	0.00	0.00	0.46	0.92	0.00	0.46	0.92
Synoviocyte, donor1	11291-117A4	52.01	0.50	0.00	0.17	0.17	1.01	0.50	0.00	0.67
Synoviocyte, donor2	11368-117I9	50.96	0.50	0.17	0.34	0.00	1.01	0.50	0.34	0.50
Synoviocyte, donor3	11440-118H9	37.53	0.22	0.00	0.22	0.22	1.12	0.67	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	126.85	0.71	0.71	0.36	0.00	0.71	0.71	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	0.00	0.00	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	48.86	0.23	0.69	0.00	0.23	0.23	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	59.35	0.29	0.07	0.22	0.07	0.22	0.07	0.07	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	46.00	0.39	0.00	0.39	0.00	0.00	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	51.54	0.00	0.00	0.57	0.00	0.57	0.00	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	93.74	0.37	0.00	0.37	0.00	1.48	0.62	0.49	0.00
Urethra, donor2	10319-105A4	113.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	30.29	0.27	0.00	0.00	0.00	0.53	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	25.24	0.00	0.00	0.00	0.00	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	23.84	0.23	0.00	0.00	0.46	0.23	0.00	0.23	0.23
Urothelial cells, donor0	11216-116B1	41.24	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	105.88	0.00	0.00	1.78	0.00	1.78	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	84.35	0.00	0.00	1.43	2.86	2.86	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	88.30	0.68	0.00	1.37	0.00	1.37	0.00	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	119.83	0.34	0.00	0.34	0.34	0.69	0.00	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	94.13	0.58	0.00	1.16	0.00	1.16	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	104.12	0.00	0.00	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	115.64	0.00	0.00	0.00	0.92	1.84	0.00	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	85.81	0.91	0.00	0.00	0.00	0.91	1.83	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	218.97	1.97	0.62	1.85	0.86	4.19	0.99	2.59	1.73
Wilms' tumor cell line:HFWT	10597-108E3	124.97	0.00	0.00	0.88	0.00	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	73.74	1.40	0.00	1.12	0.56	0.28	0.28	0.28	0.84
achilles tendon, donor2	10292-104G4	113.66	0.00	0.00	0.00	0.00	4.13	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	237.36	3.06	0.51	1.02	1.02	3.31	2.55	0.51	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	380.53	5.11	1.39	2.55	0.46	3.02	0.93	1.39	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	291.55	4.87	0.83	1.66	0.59	1.78	1.07	0.71	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	299.60	2.99	0.27	2.72	1.36	2.99	1.36	1.36	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	242.86	2.53	0.00	3.37	1.12	8.43	4.50	4.22	3.09
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	248.28	2.96	0.00	1.90	0.63	2.11	2.33	1.27	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	121.95	0.54	0.00	1.91	0.27	0.82	0.54	0.82	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	221.20	2.20	0.00	1.76	0.44	3.97	2.20	2.64	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	223.78	2.45	0.00	2.86	0.82	4.08	2.45	2.86	3.27
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	304.43	1.94	1.16	1.16	1.94	4.27	1.55	1.55	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	267.90	6.07	0.00	2.76	1.29	7.36	2.76	2.58	2.58
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	436.86	3.90	7.80	0.00	3.90	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	267.94	0.46	0.00	2.79	2.09	3.49	3.72	1.39	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	337.61	2.33	0.26	3.11	1.55	6.99	3.37	3.11	4.14
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	257.76	3.51	0.00	1.75	2.05	6.72	2.63	2.63	3.80
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	134.78	1.86	1.39	0.46	0.00	0.00	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	179.72	3.70	1.23	1.23	0.41	2.88	2.47	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	213.33	0.61	0.00	0.31	0.00	3.07	0.92	1.23	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	230.85	3.41	0.43	0.43	0.85	2.13	0.85	1.71	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	215.64	3.34	0.30	0.61	0.30	1.21	0.30	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	226.02	1.68	0.24	0.72	0.24	1.44	0.96	1.20	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	247.91	4.68	0.00	1.56	1.56	4.90	1.56	2.23	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	196.13	1.00	0.33	1.00	0.00	1.33	1.33	1.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	131.93	0.00	1.86	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	249.73	3.39	0.75	2.64	1.13	1.88	1.88	2.26	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	179.69	1.74	1.31	0.00	0.00	1.31	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	178.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	141.54	1.18	0.47	0.71	0.47	1.18	0.47	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	78.80	0.16	0.00	0.47	0.16	1.55	0.00	0.78	0.16
adipose, donor1	10184-103D4	270.33	8.80	0.59	6.45	4.69	58.05	5.28	7.62	11.14
adipose, donor2	10185-103D5	122.47	1.22	0.00	1.22	0.41	6.49	0.41	0.41	1.22
adipose, donor3	10186-103D6	147.85	5.99	1.63	0.54	0.27	9.80	3.27	1.91	1.36
adipose, donor4	10187-103D7	392.64	5.20	1.73	2.60	0.87	13.00	6.93	3.47	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	174.86	1.10	0.16	0.95	0.32	0.63	0.32	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	123.68	0.00	0.00	0.00	0.00	7.28	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	94.72	2.67	0.67	0.00	0.40	0.53	0.13	0.40	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	173.29	3.57	1.07	1.79	1.43	3.22	2.50	2.14	0.36
amniotic membrane cells, donor1	12235-129G3	64.69	0.70	0.00	0.00	0.00	0.70	0.23	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	100.42	0.68	0.68	0.00	0.00	0.34	0.68	1.01	0.34
amniotic membrane cells, donor3	12237-129G5	45.07	0.29	0.00	0.88	0.00	0.59	0.88	0.29	0.29
amygdala - adult, donor10196	10167-103B5	75.89	0.00	0.00	0.00	0.00	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	106.66	0.81	0.00	1.22	0.20	0.61	0.41	0.81	0.41
amygdala, newborn, donor10223	10360-105E9	68.43	0.00	0.00	0.65	0.00	1.94	0.65	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	89.77	1.27	0.76	0.51	0.25	1.40	0.64	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	243.57	2.43	0.88	2.43	1.54	3.97	1.32	1.54	2.65
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	478.01	8.35	7.01	5.01	1.00	2.67	1.67	2.67	2.67
aorta, adult, pool1	10052-101G7	89.63	0.00	0.00	1.37	0.59	1.18	0.78	0.98	0.98
appendix, adult	10189-103D9	170.38	0.39	0.00	1.94	0.39	2.33	1.55	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	168.18	5.16	0.34	1.72	0.00	2.75	0.34	1.72	2.06
artery, adult	10190-103E1	97.83	0.00	0.00	1.36	1.36	0.00	1.36	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	131.68	1.01	0.43	0.43	0.29	0.72	0.43	0.43	0.58
b cell line:RPMI1788	10427-106D4	182.75	0.89	0.45	0.74	0.30	0.89	0.74	0.74	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	61.87	0.00	0.00	0.83	0.28	1.11	1.11	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	124.54	1.98	1.29	0.10	0.30	0.99	0.10	0.10	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	109.97	1.51	0.67	0.67	0.17	1.34	0.50	0.67	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	133.10	2.24	0.00	1.12	1.68	3.91	0.00	1.68	0.56
bladder, adult, pool1	10011-101C2	69.31	0.22	0.00	0.33	0.22	0.54	0.54	0.33	0.11
blood, adult, pool1	10053-101G8	48.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	42.82	0.00	0.00	0.00	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	94.48	0.00	0.00	0.67	0.00	2.02	2.02	0.67	2.02
brain, adult, donor1	10084-102B3	90.21	1.03	0.00	3.08	0.00	1.03	0.00	1.03	1.03
brain, adult, pool1	10012-101C3	56.01	0.33	0.00	0.67	0.45	0.33	1.00	0.56	0.33
brain, fetal, pool1	10085-102B4	93.50	0.00	0.00	0.00	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	187.98	1.65	0.66	1.32	0.66	0.00	0.99	0.99	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	92.49	1.12	0.75	0.00	0.00	0.62	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	65.03	0.63	0.00	0.63	0.00	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	152.45	1.78	0.00	1.91	0.25	2.29	0.89	1.14	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	145.33	1.55	0.62	0.31	0.31	2.16	0.00	0.62	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	142.97	1.15	1.84	2.07	0.23	5.06	2.30	2.76	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	100.71	1.45	0.24	0.73	0.48	0.73	0.00	1.21	1.21
carcinoid cell line:NCI-H1770	10703-109H1	170.67	4.23	0.00	1.88	1.88	1.41	1.41	1.88	2.82
carcinoid cell line:NCI-H727	10735-110B6	108.18	0.98	0.22	0.33	0.11	0.33	0.11	0.11	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	175.56	1.27	0.63	2.22	1.58	4.12	2.54	1.58	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	273.36	10.11	0.53	3.46	1.60	6.39	3.73	3.19	3.46
caudate nucleus - adult, donor10196	10177-103C6	115.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	116.79	0.67	0.00	1.00	0.84	1.67	0.50	0.84	0.67
caudate nucleus, adult, donor10258	10379-105H1	84.82	0.00	0.00	0.76	0.76	0.00	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	83.13	0.00	0.37	0.37	0.37	0.37	1.10	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	294.24	11.65	0.00	2.91	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	279.70	4.06	0.21	2.78	0.85	2.56	2.99	1.07	1.71
cerebellum, adult, pool1	10083-102B2	125.21	0.34	0.00	1.38	1.03	2.07	1.72	3.10	0.69
cerebellum, newborn, donor10223	10357-105E6	207.57	2.49	0.00	2.49	1.66	4.15	2.49	0.83	2.49
cerebral meninges, adult	10188-103D8	73.12	0.25	0.00	0.00	0.00	0.76	0.50	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	87.71	0.00	0.00	1.46	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	145.80	1.58	0.86	0.43	0.72	1.15	0.14	0.43	0.58
cervical cancer cell line:ME-180	10553-107I4	141.02	2.32	0.83	0.66	0.17	1.49	0.33	0.83	0.17
cervix, adult, pool1	10013-101C4	105.94	0.84	0.00	0.42	0.31	1.57	0.63	0.10	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	96.70	1.67	0.00	0.28	0.28	1.39	0.70	0.56	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	45.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	186.29	1.37	1.37	1.49	1.37	5.47	0.50	0.87	0.00
choriocarcinoma cell line:SCH	10785-110H2	167.45	0.74	0.74	0.49	0.86	2.46	0.49	2.96	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	151.32	0.00	0.00	0.00	0.24	0.47	0.47	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	51.00	0.00	0.00	0.28	0.28	0.28	0.57	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	74.37	0.30	0.00	0.40	0.60	1.99	0.40	0.40	0.60
chorionic membrane cells, donor3	12240-129G8	75.83	0.00	0.00	1.10	0.00	3.85	2.75	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	247.40	2.02	1.01	3.03	3.03	8.08	11.11	4.04	9.09
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	199.59	1.73	0.00	2.11	0.96	1.54	1.73	0.96	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	246.67	1.27	0.21	1.27	0.21	1.48	0.42	1.48	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	142.52	3.60	0.77	0.51	0.26	1.03	1.28	1.28	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	158.67	5.81	0.48	0.24	0.48	1.21	1.21	0.24	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	177.14	3.46	0.61	0.81	0.20	0.81	0.81	1.02	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	242.63	7.66	2.06	1.18	1.18	2.65	1.18	1.18	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	264.01	1.30	1.30	1.04	0.78	1.82	0.52	0.00	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	145.61	2.06	0.46	1.60	1.37	6.86	2.74	3.66	1.60
clear cell carcinoma cell line:TEN	10636-108I6	158.58	2.78	0.69	0.52	0.00	2.08	1.21	1.74	1.04
colon carcinoma cell line:CACO-2	10513-107D9	139.84	5.49	1.46	0.92	0.92	1.46	0.55	0.55	0.73
colon carcinoma cell line:COLO-320	10420-106C6	293.80	12.92	4.56	0.76	0.38	3.04	0.38	0.00	1.90
colon, adult, donor1	10082-102B1	142.80	1.19	1.19	0.00	1.19	7.14	0.00	3.57	0.00
colon, adult, pool1	10014-101C5	96.47	0.24	0.00	0.12	0.82	1.76	0.24	0.12	0.12
colon, fetal, donor1	10070-101I7	87.14	0.00	0.62	1.24	0.00	1.24	1.24	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	458.35	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	239.24	5.52	0.85	0.00	2.12	0.42	0.85	1.27	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	219.91	5.28	0.45	1.51	0.45	3.02	0.15	0.30	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	240.14	3.24	0.71	1.41	0.56	1.69	1.13	0.42	0.85
corpus callosum, adult, pool1	10042-101F6	117.20	0.55	0.11	0.33	0.22	0.77	0.33	0.22	0.11
cruciate ligament, donor2	10295-104G7	135.35	0.00	0.81	0.00	0.00	1.62	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	83.47	0.00	0.80	0.00	0.80	0.80	0.80	1.61	0.00
diencephalon, adult	10193-103E4	68.16	0.24	0.00	0.48	0.48	0.96	0.24	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	256.48	2.30	0.69	6.66	1.15	7.81	7.35	2.76	3.90
ductal cell carcinoma cell line:KLM-1	10438-106E6	82.32	0.26	0.51	0.26	0.00	0.77	0.00	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	90.27	0.00	0.24	0.96	0.00	2.17	0.24	1.44	0.48
ductus deferens, adult	10196-103E7	143.02	0.50	0.00	1.50	0.50	1.00	1.50	0.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	103.70	0.00	0.00	2.88	0.00	2.88	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	123.59	1.47	0.00	1.47	2.94	7.36	4.41	2.94	1.47
dura mater, adult, donor1	10041-101F5	95.55	0.41	0.00	0.41	0.33	0.33	0.00	0.50	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	147.46	19.32	13.77	0.67	0.67	5.11	0.89	2.44	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	219.96	8.31	2.29	1.43	1.29	3.44	1.29	1.00	2.29
embryonic pancreas cell line:1B2C6	10604-108F1	70.29	1.23	0.00	0.62	0.00	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	96.56	1.51	0.30	0.91	0.30	0.91	0.61	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	89.23	0.93	0.31	0.31	0.00	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	90.63	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	61.68	1.34	0.00	0.00	0.34	0.34	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	81.56	1.09	0.00	0.36	0.54	1.99	0.18	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	122.70	1.61	0.16	1.77	0.64	1.45	2.73	0.80	1.13
epidermoid carcinoma cell line:A431	10426-106D3	83.15	0.89	0.00	0.00	0.11	0.22	0.22	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	145.84	3.08	1.76	0.66	0.33	1.10	0.11	0.33	0.22
epididymis, adult	10197-103E8	95.66	0.63	0.00	0.42	1.26	1.26	0.84	0.42	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	81.96	1.60	0.00	0.71	0.35	0.18	0.18	0.53	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	87.69	0.79	0.00	0.00	0.00	0.39	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	260.00	7.86	0.79	1.83	1.44	3.80	4.06	2.75	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	234.14	7.87	0.79	1.38	0.59	2.17	2.17	0.89	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	276.60	7.95	1.12	2.02	1.23	2.35	2.24	1.01	0.90
esophagus, adult, pool1	10015-101C6	70.40	0.42	0.11	0.21	0.32	1.27	0.32	0.11	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	138.64	1.75	0.13	0.13	0.25	0.63	0.25	0.25	0.25
eye - muscle inferior rectus, donor1	10272-104E2	130.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	96.79	0.00	0.00	2.10	0.00	2.10	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	98.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	112.36	0.00	0.00	3.44	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	91.82	0.00	0.00	0.00	0.00	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	71.44	0.51	0.25	0.25	0.51	0.76	0.76	0.00	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	136.17	1.92	0.00	1.03	0.64	1.28	0.64	1.15	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	167.14	2.14	0.71	0.24	0.47	0.47	1.90	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	89.23	0.47	0.00	0.28	0.09	0.28	0.47	0.47	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	197.26	2.40	1.50	0.90	0.30	5.10	1.20	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	78.18	1.37	0.27	0.09	0.00	0.55	0.00	0.09	0.09
gall bladder, adult	10198-103E9	97.30	0.48	0.00	0.00	0.24	0.72	0.48	0.48	0.97
gamma delta positive T cells, donor1	11937-126A2	166.96	2.68	0.00	0.00	0.00	2.15	0.00	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	97.85	0.00	0.00	0.75	0.75	2.61	0.75	0.75	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	73.29	0.42	0.00	1.69	0.84	1.06	0.63	0.84	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	147.00	1.35	0.00	0.39	0.58	1.16	0.19	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	175.60	5.57	0.66	0.33	0.00	1.15	0.33	0.66	0.82
gastric cancer cell line:GSS	10560-108A2	126.30	0.00	0.00	0.92	0.00	2.75	0.92	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	136.85	1.37	0.69	1.14	1.14	3.43	4.34	1.37	1.37
giant cell carcinoma cell line:LU65	10487-107B1	57.03	2.41	1.03	0.34	0.69	1.03	0.23	0.34	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	142.48	0.84	0.28	0.00	0.56	0.84	0.28	0.28	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	149.65	1.50	0.00	0.50	1.00	1.25	0.50	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	90.99	0.95	0.21	0.00	0.11	0.63	0.21	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	95.50	1.83	0.00	0.00	0.14	0.70	0.28	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	157.06	2.32	1.32	0.55	0.33	0.77	0.66	0.99	0.44
glioma cell line:GI-1	10413-106B8	114.81	0.88	0.00	0.59	0.00	1.46	0.00	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	110.79	0.00	0.00	0.73	0.73	1.46	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	168.43	2.20	0.00	0.98	0.24	0.98	0.98	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	95.84	0.00	0.00	1.37	0.00	0.00	2.74	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	67.15	0.00	0.00	0.53	0.00	0.00	1.07	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	374.41	7.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	174.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	109.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	75.52	0.32	0.00	0.32	0.00	0.32	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	157.02	6.89	3.21	0.92	0.46	3.67	3.21	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	162.79	7.77	3.20	0.00	1.37	4.57	1.37	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	148.79	8.37	1.93	0.00	0.00	3.86	1.29	2.58	2.58
hIPS, biol_rep1	14380-156B6	186.85	1.44	0.00	0.00	0.00	4.31	1.44	2.87	4.31
hIPS, biol_rep2	14381-156B7	161.18	5.49	3.43	0.00	0.69	4.80	2.06	8.23	0.69
hIPS, biol_rep3	14382-156B8	99.31	0.00	0.00	1.10	0.00	2.21	2.21	3.31	1.10
hairy cell leukemia cell line:Mo	10712-109I1	164.36	2.30	0.29	1.44	0.57	4.31	1.15	2.01	0.57
heart - mitral valve, adult	10205-103F7	84.91	0.30	0.00	0.90	1.49	1.49	0.30	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	74.52	0.00	0.00	0.00	0.26	0.52	0.52	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	126.56	0.00	0.00	0.83	0.00	2.50	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	97.95	0.20	0.00	1.02	0.61	1.43	1.43	1.63	1.02
heart, adult, diseased, donor1	10051-101G6	61.32	0.00	0.00	0.43	0.43	0.00	0.85	0.85	0.00
heart, adult, pool1	10016-101C7	42.78	0.00	0.00	0.00	0.00	0.23	0.00	0.46	0.00
heart, fetal, pool1	10046-101G1	107.10	0.72	0.00	0.10	0.31	0.51	0.41	0.41	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	54.92	0.31	0.00	0.31	0.00	0.00	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	141.51	2.38	1.19	0.00	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	273.15	6.30	0.55	1.33	0.66	1.88	1.44	1.22	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	286.20	6.19	1.21	2.91	1.70	1.94	3.28	1.58	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	299.82	6.47	1.01	1.41	1.21	2.12	2.32	1.11	0.71
hepatoma cell line:Li-7	10484-107A7	131.90	2.67	0.33	1.56	0.11	1.67	0.33	0.78	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	208.24	2.41	0.90	1.51	0.70	1.31	0.60	0.70	1.01
hippocampus - adult, donor10196	10169-103B7	86.12	0.95	0.00	0.95	0.95	0.95	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	114.70	0.20	0.00	0.82	0.20	0.61	1.84	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	70.71	0.00	0.00	0.50	0.50	1.00	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	69.44	0.70	0.00	0.00	0.00	1.41	0.70	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	279.54	14.04	9.77	7.93	3.05	17.09	14.65	4.88	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	197.53	9.03	4.12	0.98	0.79	6.87	2.75	2.95	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	192.71	8.38	6.86	1.52	0.25	6.86	3.05	1.27	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	153.93	6.77	1.69	0.56	1.13	11.84	1.13	2.82	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	203.21	6.97	0.26	5.68	5.16	42.09	16.01	7.75	8.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	186.39	9.49	2.66	0.76	1.14	16.32	6.07	2.28	7.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	179.84	8.47	1.17	0.88	1.17	18.39	2.34	4.67	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	169.76	7.97	1.51	1.29	1.51	14.65	2.37	1.51	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	149.31	5.42	2.09	0.42	2.09	14.18	1.25	4.17	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	205.77	4.97	0.71	1.42	0.00	7.58	1.18	0.71	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	194.95	5.46	1.61	0.64	1.45	14.14	3.54	3.21	4.82
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	202.66	4.71	0.67	0.67	1.35	8.75	1.35	2.02	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	152.10	6.10	5.79	2.35	1.25	5.79	4.07	2.97	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	163.60	9.33	6.39	5.40	0.98	18.18	13.26	6.39	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	194.62	8.73	5.24	3.49	1.75	13.09	9.60	7.85	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	194.35	7.25	0.95	1.53	2.29	13.94	3.05	2.10	4.20
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	169.20	6.11	1.31	0.44	0.87	9.59	3.05	3.05	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	156.43	6.50	3.50	7.00	1.00	33.98	6.00	7.00	8.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	119.63	1.51	0.57	1.13	1.88	7.91	2.26	2.07	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	120.50	1.36	0.45	0.91	0.91	12.28	1.82	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	116.52	2.51	0.63	0.63	1.25	6.89	3.45	1.57	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	125.74	3.59	0.49	0.65	1.63	11.76	1.80	2.45	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	119.61	2.03	0.58	1.16	1.45	9.29	1.45	1.45	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	102.53	3.89	0.30	0.60	0.00	9.86	1.49	0.90	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	186.04	6.28	5.17	2.22	0.55	5.91	2.96	2.22	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	169.17	7.13	2.57	0.29	0.57	5.99	1.71	1.71	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	252.34	12.66	3.67	1.22	1.63	6.94	6.94	5.31	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	157.38	5.28	0.70	1.41	2.11	20.42	4.58	6.34	4.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	140.63	5.38	1.27	1.27	0.32	10.45	2.53	1.58	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	137.99	5.14	1.21	0.91	1.21	13.92	2.72	1.82	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	126.69	1.55	0.00	0.52	0.52	9.31	1.03	1.55	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	146.12	2.66	1.33	0.66	0.00	5.98	1.33	2.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	119.80	2.82	0.51	0.00	0.77	4.10	1.03	0.51	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	125.78	4.60	1.28	2.05	0.26	6.90	4.86	3.58	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	146.14	2.27	0.76	1.51	2.27	10.60	4.54	2.27	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	127.70	4.70	1.01	0.67	1.01	7.73	2.35	0.67	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	180.65	8.45	5.80	1.45	0.72	6.28	5.07	3.38	3.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	164.45	5.35	6.24	1.78	2.23	12.92	4.90	3.12	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	193.17	8.29	5.37	1.95	1.46	8.78	4.88	5.85	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	164.12	6.72	1.53	0.00	2.14	18.64	3.06	3.36	2.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	614.86	19.52	0.00	6.51	13.01	195.19	48.80	35.79	35.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	196.91	6.95	2.65	2.32	2.65	31.77	5.30	5.30	5.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	151.05	4.38	1.64	1.64	0.55	12.59	1.64	1.64	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	118.34	4.70	0.72	0.72	0.72	11.22	1.09	2.53	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	133.10	4.98	1.78	0.00	1.42	8.19	1.07	1.42	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	108.60	11.93	0.00	0.00	0.00	8.35	3.58	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	194.47	6.91	0.95	0.54	0.41	14.36	1.76	1.90	3.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	137.66	2.42	1.08	0.81	0.54	7.27	1.62	0.54	1.35
immature langerhans cells, donor1	11904-125F5	43.83	0.00	0.00	0.73	0.24	0.73	0.00	0.73	0.24
immature langerhans cells, donor2	11905-125F6	89.51	0.00	0.00	0.79	0.00	0.79	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	87.16	0.19	0.00	0.19	0.28	0.57	0.28	0.38	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	100.47	0.65	0.00	0.98	0.98	1.30	0.00	1.30	0.33
kidney, adult, pool1	10017-101C8	91.42	0.40	0.10	0.60	0.20	1.10	0.80	0.50	0.10
kidney, fetal, pool1	10045-101F9	107.09	0.35	0.07	0.07	0.35	0.21	0.28	0.28	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	96.72	0.71	0.00	0.14	0.14	0.57	0.00	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	76.03	0.83	0.00	1.52	0.41	3.04	0.83	0.83	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	90.65	0.92	0.37	0.18	0.37	0.73	0.00	0.18	0.37
left atrium, adult, donor1	10079-102A7	44.13	0.00	0.00	0.00	0.00	2.72	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	34.89	0.51	0.00	0.51	0.00	0.51	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	227.10	2.46	0.00	1.09	0.82	0.27	0.00	0.82	0.55
leiomyoma cell line:10964C	10569-108B2	39.16	0.00	0.36	0.36	0.00	1.44	1.44	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	46.74	0.00	0.00	0.54	1.09	1.09	1.63	2.17	1.09
leiomyoma cell line:15425	10571-108B4	71.15	0.00	0.00	1.21	1.21	3.16	1.94	1.21	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	158.92	4.18	2.09	0.00	0.00	2.09	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	206.84	1.53	0.83	1.53	0.71	1.30	0.35	1.06	1.18
liposarcoma cell line:KMLS-1	10782-110G8	97.48	0.47	0.31	1.72	0.16	1.09	0.78	0.62	0.31
liposarcoma cell line:SW 872	10726-110A6	124.15	1.10	0.24	0.37	0.37	0.73	0.24	0.49	0.73
liver, adult, pool1	10018-101C9	77.30	0.81	0.00	0.65	0.49	0.81	0.16	0.32	0.16
liver, fetal, pool1	10086-102B5	63.97	0.00	0.00	0.94	0.00	1.88	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	82.54	0.15	0.00	0.44	0.00	0.87	0.15	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	123.83	2.03	0.00	1.11	0.37	0.92	0.92	0.92	0.55
locus coeruleus, adult, donor10258	10375-105G6	72.51	0.56	0.00	0.56	1.13	1.13	2.26	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	99.69	1.26	0.00	0.00	1.68	3.79	0.42	1.26	1.26
lung adenocarcinoma cell line:A549	10499-107C4	74.73	0.42	0.00	0.42	0.42	0.28	0.00	0.00	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	57.91	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	97.68	0.66	0.26	0.00	0.53	0.26	0.40	0.26	0.26
lung, adult, pool1	10019-101D1	63.20	0.24	0.00	0.00	0.00	0.95	0.24	0.35	0.24
lung, fetal, donor1	10068-101I5	136.42	2.00	0.00	1.71	0.00	2.85	0.29	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	94.85	0.00	0.00	0.46	0.92	2.75	0.46	0.00	0.92
lymph node, adult, donor1	10077-102A5	86.63	0.00	0.00	1.89	0.47	0.47	0.95	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	121.42	0.66	0.00	0.00	0.22	2.63	0.44	0.44	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	216.28	3.02	0.91	1.06	0.15	1.36	1.21	1.36	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	123.18	0.85	0.85	0.00	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	96.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	98.58	0.42	0.21	0.42	0.42	1.04	0.00	1.04	0.00
mature adipocyte, donor3	12233-129G1	87.71	0.71	0.00	0.00	0.47	0.71	0.47	0.00	0.24
mature adipocyte, donor4	12234-129G2	82.39	0.26	0.00	0.53	0.00	0.00	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	163.21	2.62	0.71	0.24	0.00	0.24	0.24	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	99.27	0.00	0.00	1.13	0.00	0.00	1.13	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	105.93	0.37	0.18	0.92	0.18	2.02	0.74	0.55	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	62.27	0.00	0.00	0.32	0.95	0.32	1.59	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	75.49	1.71	0.00	0.43	0.00	1.28	2.56	2.13	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	85.89	0.17	0.00	1.52	1.52	6.24	2.03	2.70	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	115.66	0.64	0.00	2.55	0.42	0.21	1.27	0.64	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	258.37	0.00	0.00	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	64.25	0.36	0.36	0.72	0.00	1.08	1.44	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	118.11	1.30	0.00	0.65	0.00	1.95	2.60	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	130.65	1.86	0.00	1.39	0.00	0.62	0.77	0.93	0.46
medulla oblongata, adult, pool1	10038-101F2	87.50	0.16	0.00	0.16	0.33	0.65	0.08	0.33	0.00
medulla oblongata, newborn, donor10223	10361-105F1	78.12	1.74	0.00	0.69	0.35	1.39	1.04	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	536.04	14.39	5.76	5.09	3.10	12.18	8.41	7.53	3.99
medulloblastoma cell line:ONS-76	10759-110E3	181.33	0.86	0.12	0.73	0.24	1.71	0.12	0.98	0.12
melanoma cell line:COLO 679	10514-107E1	125.63	0.29	0.43	0.57	0.43	2.87	0.29	0.72	0.29
melanoma cell line:G-361	10465-106H6	106.68	0.27	0.00	1.09	0.81	4.61	1.09	0.54	1.36
meningioma cell line:HKBMM	10691-109F7	45.77	0.36	0.00	0.72	0.36	0.72	1.09	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	441.46	12.34	0.88	2.64	5.29	8.81	3.52	4.41	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	427.72	10.89	0.78	4.93	1.30	2.33	3.63	2.33	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	108.94	0.46	0.31	0.77	0.15	1.23	1.53	0.77	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	73.44	0.00	0.18	0.55	0.36	1.27	0.36	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	58.80	0.41	0.00	0.41	0.41	0.41	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	51.55	0.28	0.00	0.14	0.00	0.00	0.28	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	51.03	0.19	0.00	1.16	0.19	0.77	0.96	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	51.36	0.00	0.00	0.00	0.69	0.69	0.00	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	38.10	0.00	0.17	0.17	0.17	0.51	0.51	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	56.47	0.58	0.00	0.58	0.12	0.92	0.81	0.46	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	82.77	0.27	0.00	0.53	0.00	1.06	1.46	0.00	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	90.21	0.54	0.14	0.41	0.41	1.22	0.54	0.68	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	91.90	0.57	0.00	0.85	0.14	0.71	0.85	0.14	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	63.89	0.33	0.00	0.99	0.33	0.33	0.99	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	84.27	0.14	0.00	0.28	0.14	0.83	0.55	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	69.47	0.70	0.35	0.00	0.35	0.70	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.40	0.61	0.00	0.82	0.00	1.02	0.20	0.41	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	53.56	1.08	0.00	0.36	0.00	1.08	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	35.38	0.21	0.00	0.52	0.10	0.72	0.31	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	42.18	0.00	0.23	0.00	0.23	0.68	0.91	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	137.20	1.68	0.00	0.84	0.00	2.52	2.52	1.26	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	74.12	0.30	0.00	0.15	0.45	1.34	0.60	0.60	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	54.97	0.44	0.00	0.61	0.35	0.44	0.44	0.70	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	53.01	0.37	0.00	0.37	0.00	2.21	0.74	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	53.23	0.00	0.00	0.86	0.86	0.00	1.14	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	165.46	3.37	0.00	2.53	1.26	4.63	7.16	4.63	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	72.61	0.46	0.00	1.83	0.91	1.37	0.46	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	72.39	0.00	0.00	0.51	0.26	0.51	0.77	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	74.60	0.00	0.00	0.26	1.31	1.05	0.26	0.52	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	80.41	1.23	0.00	0.62	0.00	2.46	0.31	1.23	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	70.84	0.00	0.00	0.24	0.24	1.18	0.71	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	81.57	1.02	0.00	1.35	0.00	1.35	1.02	1.02	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	73.49	0.79	0.00	0.00	0.39	3.14	2.36	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	72.75	0.00	0.00	0.93	0.46	1.39	0.00	0.00	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	90.27	0.29	0.00	0.58	0.29	1.44	2.02	1.15	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	75.18	0.67	0.00	0.45	0.45	2.23	1.12	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	71.87	0.24	0.00	0.00	0.24	1.44	0.96	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	80.67	0.00	0.00	2.20	0.00	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	68.47	0.34	0.00	0.34	0.00	1.68	1.01	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	62.63	0.00	0.00	0.82	0.41	1.64	1.23	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	71.31	0.86	0.43	0.00	0.43	1.29	0.86	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	87.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	5.16	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	77.95	0.32	0.00	0.32	0.32	1.30	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	74.20	0.00	0.00	1.45	0.00	4.36	2.91	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	72.50	0.00	0.00	1.60	0.53	2.67	0.00	1.60	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	63.79	0.82	0.00	1.64	0.00	2.45	1.64	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	73.08	0.39	0.00	1.55	0.00	1.17	0.39	1.94	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	71.36	0.00	0.00	0.00	2.10	2.10	0.00	4.20	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	55.63	0.00	0.00	0.99	0.99	2.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	71.51	0.00	0.00	0.00	0.00	4.77	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	71.75	0.00	0.00	0.59	0.59	1.19	0.59	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	74.33	0.00	0.00	0.00	0.00	3.66	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	52.57	0.00	0.00	0.00	1.27	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	50.70	0.69	0.00	0.34	0.00	0.69	0.34	1.03	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	60.18	0.00	0.00	0.00	0.00	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	0.00	0.00	0.00	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	0.00	0.00	3.44	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	37.08	0.41	0.41	0.41	0.81	1.22	0.81	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	36.54	0.79	0.79	0.00	0.79	2.38	0.00	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	0.00	0.00	2.36	0.00	1.18	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	43.95	0.00	0.00	0.31	0.31	1.25	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	0.00	0.00	1.34	1.34	1.34	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	73.33	0.00	0.00	0.00	3.55	7.10	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	71.90	0.00	0.00	0.00	2.57	2.57	2.57	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	71.59	0.69	0.00	0.69	0.69	3.44	2.07	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	75.21	0.00	0.00	0.49	0.00	2.97	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	59.44	0.00	0.00	0.00	0.00	1.12	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	65.51	0.00	0.00	1.27	0.00	3.82	1.91	3.18	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	65.69	0.00	0.00	0.81	0.00	2.01	0.40	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	69.78	0.00	0.00	2.18	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	51.95	0.00	0.00	0.00	0.00	5.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	63.72	0.00	0.00	0.00	0.61	1.82	0.00	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	0.00	4.52	0.00	4.52	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	49.42	0.00	0.00	0.82	0.00	0.82	0.82	1.65	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	54.37	0.00	0.00	0.00	0.40	1.39	0.60	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	52.57	0.00	0.00	0.32	0.32	1.62	0.65	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	52.97	0.00	0.00	0.00	0.00	4.07	3.06	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	49.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	65.44	1.65	0.47	0.24	0.00	0.71	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	109.35	1.16	0.00	0.46	0.23	0.23	0.23	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	65.45	1.03	0.10	0.82	0.92	1.85	1.13	0.51	0.31
mesothelioma cell line:Mero-25	10850-111F4	59.69	0.45	0.23	0.91	0.23	0.91	1.13	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	109.04	1.22	0.00	1.22	0.49	1.22	0.24	1.47	0.73
mesothelioma cell line:Mero-48a	10852-111F6	96.99	0.44	0.22	0.66	0.66	3.76	0.22	0.22	2.21
mesothelioma cell line:Mero-82	10853-111F7	136.92	0.26	0.00	1.31	0.53	4.47	1.05	2.63	2.63
mesothelioma cell line:Mero-83	10854-111F8	123.24	0.68	0.34	1.70	0.85	3.40	1.70	2.04	0.85
mesothelioma cell line:Mero-84	10855-111F9	85.44	0.25	0.00	0.25	1.26	1.26	0.25	1.52	0.76
mesothelioma cell line:Mero-95	10856-111G1	89.03	1.24	0.00	0.41	0.83	2.07	1.24	0.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	131.19	1.16	0.33	2.15	0.50	4.31	0.66	2.48	1.33
mesothelioma cell line:NCI-H226	10846-111E9	121.45	0.72	0.00	0.54	0.90	2.71	1.27	1.99	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	94.12	2.39	0.17	1.54	0.68	1.88	0.85	2.05	1.37
mesothelioma cell line:NCI-H28	10845-111E8	174.05	4.83	2.29	3.56	1.78	4.58	2.29	1.78	1.27
mesothelioma cell line:No36	10857-111G2	120.69	3.59	0.00	0.65	0.65	3.59	1.30	1.96	1.63
mesothelioma cell line:ONE58	10858-111G3	123.28	1.90	0.00	0.54	1.63	3.25	1.35	2.17	1.63
migratory langerhans cells, donor1	11901-125F2	44.72	0.00	0.00	0.19	0.19	0.77	0.38	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	64.23	0.24	0.00	0.24	0.00	1.47	0.49	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	68.92	0.00	0.00	0.54	0.36	0.54	0.18	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	70.85	1.63	0.00	0.98	0.98	2.94	1.96	2.29	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	95.58	0.42	0.00	1.91	0.64	1.70	1.91	0.85	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	182.90	0.69	0.00	0.69	0.00	0.23	0.00	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	135.11	1.14	0.00	0.38	0.00	1.33	0.57	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	303.80	4.07	0.55	1.85	1.11	1.48	1.48	2.77	0.55
myeloma cell line:PCM6	10474-106I6	68.20	0.59	0.00	0.20	0.20	0.99	0.40	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	91.82	0.51	0.00	0.00	0.00	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	97.09	3.53	0.78	0.59	0.00	0.78	0.59	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	29.19	0.22	0.11	0.11	0.00	0.00	0.11	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	27.58	0.37	0.00	0.07	0.22	0.07	0.15	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	131.37	0.00	0.00	1.10	0.00	1.10	0.00	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	323.93	4.14	1.38	0.92	0.46	1.38	0.46	0.69	0.92
neuroblastoma cell line:NB-1	10539-107G8	295.03	4.30	0.19	1.31	0.37	2.43	0.75	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	172.51	3.80	1.69	2.74	0.84	3.59	1.48	0.84	1.90
neuroblastoma cell line:NH-12	10555-107I6	405.50	9.69	3.35	2.61	1.12	3.54	0.93	2.80	2.80
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	249.80	3.80	0.71	1.42	1.66	4.74	3.56	1.42	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	195.92	1.74	0.48	1.74	0.63	3.33	3.33	2.38	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	223.00	2.42	0.00	1.61	0.81	3.22	0.40	0.40	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	205.99	1.27	0.64	0.64	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	88.37	0.80	0.27	0.00	0.53	0.00	0.00	0.00	0.53
neutrophil PMN, donor1	12133-128D9	148.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	123.12	0.00	0.00	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	420.43	3.55	0.85	1.86	0.51	3.72	0.85	1.01	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	180.91	2.40	0.80	0.80	0.80	0.80	0.00	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	70.85	0.64	0.00	0.32	0.32	2.56	0.64	3.53	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	81.46	0.26	0.26	0.53	0.53	1.84	1.84	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	92.52	0.37	0.09	0.37	0.19	0.28	0.19	0.28	0.19
occipital cortex - adult, donor10196	10172-103C1	100.96	2.06	0.00	0.00	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	163.70	1.61	0.00	1.61	0.27	2.42	1.07	0.54	0.81
occipital cortex, newborn, donor10223	10355-105E4	69.15	0.36	0.73	0.00	0.00	0.36	1.09	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	83.18	0.00	0.00	1.84	0.26	0.52	0.00	1.57	1.05
occipital lobe, fetal, donor1	10073-102A1	192.24	0.00	0.00	2.57	1.29	0.86	0.86	3.00	0.43
occipital pole, adult, pool1	10036-101E9	67.25	0.24	0.00	0.16	0.16	0.16	0.08	0.08	0.16
olfactory region, adult	10195-103E6	69.16	0.57	0.00	0.57	0.38	0.96	0.76	0.57	0.19
optic nerve, donor1	10277-104E7	140.07	2.00	0.00	0.00	0.00	2.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	101.83	2.96	0.46	0.23	0.34	1.82	0.23	0.34	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	217.48	3.85	1.79	0.82	0.27	2.06	0.55	1.10	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	82.12	0.68	0.00	1.02	0.34	1.02	2.20	0.17	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	78.89	1.39	0.35	0.58	0.35	1.04	0.69	0.35	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	63.20	0.00	0.00	0.00	0.00	0.88	0.29	0.29	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	79.42	0.93	0.00	0.00	0.00	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	138.26	0.64	0.21	1.48	0.42	1.70	0.64	0.00	0.21
ovary, adult, pool1	10020-101D2	77.74	0.26	0.00	0.26	0.09	0.70	0.17	0.17	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	86.89	0.00	0.18	0.18	0.00	1.28	0.18	0.55	0.37
pancreas, adult, donor1	10049-101G4	84.66	0.00	0.00	0.00	1.88	1.88	0.00	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	155.14	0.56	1.68	0.56	1.12	2.80	0.56	0.56	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	144.12	2.21	0.85	2.73	1.36	4.26	3.92	2.38	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	129.65	3.97	0.00	0.66	0.17	0.99	0.33	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	88.59	0.00	0.00	0.27	0.09	0.09	0.37	0.09	0.18
parietal cortex, adult, donor10258	10373-105G4	106.43	0.00	0.00	0.00	0.73	2.94	0.73	1.47	1.47
parietal lobe - adult, donor10196	10171-103B9	88.41	0.00	0.00	0.94	0.94	1.88	0.00	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	105.75	0.29	0.00	2.85	0.57	1.43	1.14	1.14	0.29
parietal lobe, adult, pool1	10034-101E7	79.84	0.44	0.00	0.35	0.35	0.26	0.35	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	171.66	0.97	0.00	4.85	2.91	3.88	6.79	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	57.57	1.12	0.00	0.37	1.12	1.50	0.37	0.00	0.75
parotid gland, adult	10199-103F1	80.17	0.62	0.62	1.23	0.00	0.00	0.62	2.47	0.00
penis, adult	10200-103F2	94.53	1.07	0.00	1.07	1.61	4.83	1.61	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	64.33	0.00	0.00	0.74	0.37	0.56	0.93	1.12	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	120.78	1.17	0.15	1.17	0.15	2.33	1.17	1.17	1.46
pineal gland - adult, donor10196	10179-103C8	123.85	0.65	0.00	1.29	1.29	1.94	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	185.36	2.37	0.00	1.18	0.59	1.78	0.59	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	70.86	0.00	0.00	0.63	0.00	3.14	0.00	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	176.05	0.00	0.00	3.04	1.01	0.00	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	227.76	2.61	0.00	1.56	0.00	0.52	0.52	2.61	0.52
pituitary gland, adult, donor10258	10378-105G9	115.77	0.85	0.00	0.00	0.85	2.55	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	77.83	0.11	0.00	0.22	0.22	0.54	0.22	0.11	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	156.13	2.38	1.46	1.06	0.40	2.91	1.19	1.06	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	88.71	0.62	0.00	0.31	0.62	0.93	0.62	0.93	1.09
pons, adult, pool1	10033-101E6	78.75	0.34	0.00	0.34	0.43	0.34	0.26	0.09	0.17
postcentral gyrus, adult, pool1	10032-101E5	81.94	0.09	0.00	0.09	0.09	0.52	0.09	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	269.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	159.06	4.22	0.00	1.31	0.29	2.77	1.17	1.17	0.87
prostate cancer cell line:PC-3	10439-106E7	199.83	2.36	0.36	1.27	0.91	1.63	0.73	1.63	1.09
prostate, adult, pool1	10022-101D4	77.81	0.54	0.09	0.36	0.27	0.91	0.09	0.18	0.09
putamen, adult, donor10196	10176-103C5	123.70	0.24	0.00	1.89	0.00	0.47	1.65	0.24	0.24
putamen, adult, donor10252	10152-102I8	105.88	0.00	0.00	0.00	3.92	1.96	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	71.03	2.19	0.00	0.00	0.00	2.19	1.09	2.19	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	77.07	0.97	0.00	0.48	0.97	0.72	0.48	0.24	0.24
putamen, newborn, donor10223	10365-105F5	77.22	1.50	0.00	0.00	0.00	2.25	0.75	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	75.06	2.04	0.29	0.00	0.29	0.29	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	272.63	1.39	0.00	1.39	2.78	0.00	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	84.16	1.48	0.42	0.42	0.64	0.85	0.64	1.27	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.58	1.24	0.00	0.00	0.41	2.07	0.83	0.41	1.66
retina, adult, pool1	10030-101E3	116.50	0.89	0.00	0.40	0.20	0.70	0.40	0.50	0.40
retinoblastoma cell line:Y79	10475-106I7	323.19	15.85	2.86	3.90	3.12	1.82	1.56	2.60	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	261.63	1.72	0.61	1.35	1.11	1.60	0.61	1.35	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	215.68	3.09	1.12	1.12	0.28	1.41	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	60.63	0.00	0.00	0.76	0.00	0.76	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	74.45	0.16	0.00	0.16	0.16	1.46	0.16	0.32	0.65
salivary acinar cells, donor2	11772-123I8	84.95	0.28	0.00	0.69	0.83	2.07	1.38	1.24	0.83
salivary acinar cells, donor3	11773-123I9	58.26	0.00	0.00	0.00	0.00	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	92.08	0.00	0.00	0.00	0.57	1.14	1.14	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	79.34	1.01	0.00	0.25	0.34	0.84	0.00	0.25	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	85.58	1.18	0.00	0.47	0.00	0.47	0.35	0.47	0.35
seminal vesicle, adult	10201-103F3	105.81	0.00	0.53	1.59	3.17	3.70	1.06	4.76	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	154.50	3.64	2.67	0.97	0.00	1.21	4.37	0.49	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	80.27	0.50	0.00	1.01	0.50	1.76	0.50	1.01	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	138.49	0.00	1.00	1.00	1.00	0.00	1.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	105.71	0.94	0.40	0.81	0.40	1.48	0.67	0.94	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	135.06	1.22	0.77	0.11	0.44	0.99	0.22	0.77	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	145.41	1.94	0.00	0.26	0.52	0.77	0.39	0.65	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	127.68	0.00	0.00	0.00	0.00	1.42	0.00	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	66.21	0.24	0.00	0.00	0.48	0.24	0.00	0.36	0.24
skeletal muscle, fetal, donor1	10066-101I3	88.44	0.00	0.00	0.00	1.01	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	67.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	153.39	1.89	0.00	3.79	1.89	1.89	1.89	1.26	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	192.44	8.67	0.00	0.33	0.33	2.33	1.00	1.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	256.58	8.20	2.21	6.30	1.89	4.10	3.47	4.73	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	226.29	1.93	0.19	1.73	0.77	3.47	2.12	2.89	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	273.12	6.43	2.31	0.66	0.66	1.48	0.33	0.49	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	358.37	11.90	3.38	3.22	2.09	4.18	3.22	2.73	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	103.73	3.49	0.22	0.87	0.65	1.74	0.22	0.22	0.00
small intestine, adult, pool1	10024-101D6	99.97	0.24	0.12	0.60	0.12	1.67	0.72	0.24	0.36
small intestine, fetal, donor1	10064-101I1	108.35	0.98	0.25	2.95	0.25	1.47	1.72	0.74	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	97.45	4.10	0.00	0.00	1.03	1.54	5.64	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	117.60	0.26	0.00	0.52	0.52	1.29	1.29	0.26	0.52
somatostatinoma cell line:QGP-1	10781-110G7	121.95	0.27	0.00	0.00	0.27	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	100.94	0.23	0.00	0.69	0.92	1.15	0.69	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	124.98	0.79	0.39	1.18	0.00	0.79	0.79	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	83.71	0.69	0.00	0.69	0.00	2.08	0.69	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	161.61	1.22	0.00	2.44	1.83	1.83	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	114.80	0.92	0.00	0.92	0.00	4.13	2.30	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	81.10	0.15	0.15	0.15	0.15	0.60	0.45	0.15	0.00
spleen, adult, pool1	10025-101D7	89.32	0.55	0.00	0.11	0.55	0.99	0.44	0.22	0.33
spleen, fetal, pool1	10044-101F8	107.26	0.87	0.00	0.16	0.16	0.32	0.24	0.16	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	134.36	2.69	0.52	0.31	0.21	0.62	0.72	0.31	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	64.94	0.38	0.00	0.19	0.38	1.14	0.00	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	137.33	0.35	0.00	1.75	1.40	2.80	1.75	2.10	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	73.89	1.17	0.39	0.00	0.00	0.00	0.00	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	54.93	1.01	0.00	0.11	0.11	0.45	0.45	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	174.10	2.12	1.27	2.12	0.85	1.69	3.81	0.85	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	95.19	1.69	0.00	0.00	0.00	0.85	0.42	0.00	0.85
stomach, fetal, donor1	10062-101H8	163.40	0.00	0.00	1.07	1.07	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	92.29	1.14	0.57	2.28	1.14	0.00	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	0.00	54.27	0.00	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	138.54	1.45	0.00	1.87	0.62	1.45	0.42	0.00	0.83
substantia nigra, adult, donor10258	10371-105G2	79.66	0.00	0.00	1.03	0.52	1.03	0.00	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	74.19	0.71	0.71	0.00	0.71	0.71	1.41	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	167.59	1.60	1.15	1.38	0.23	1.83	0.69	0.92	0.69
temporal lobe, adult, pool1	10031-101E4	71.38	0.42	0.00	0.34	0.34	0.59	0.17	0.08	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	215.82	0.71	0.00	2.85	1.42	1.42	1.42	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	135.38	1.32	0.00	1.76	0.44	2.64	1.76	2.64	0.00
tenocyte, donor1	11763-123H8	67.73	0.00	0.35	2.09	0.35	1.75	1.75	0.35	1.40
tenocyte, donor2	11765-123I1	57.23	0.38	0.00	0.38	0.38	0.38	0.76	0.76	0.38
tenocyte, donor3	11768-123I4	57.82	0.00	0.00	1.48	0.74	1.85	0.74	0.74	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	353.52	2.72	2.04	4.08	1.19	4.25	1.53	2.72	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	156.15	4.93	1.08	2.00	1.08	4.32	2.31	1.39	1.23
teratocarcinoma cell line:PA-1	10807-111A6	203.33	3.25	1.86	1.39	2.01	4.34	1.24	1.55	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	203.37	3.17	3.94	1.27	1.02	4.06	0.76	0.89	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	193.25	4.54	2.27	0.76	0.76	0.38	0.38	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	70.56	0.22	0.33	0.33	0.00	0.98	0.33	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	145.59	0.98	1.30	0.33	0.33	3.26	2.61	2.61	1.63
testis, adult, pool1	10026-101D8	72.91	2.25	0.21	0.21	1.07	2.36	0.32	0.32	0.97
testis, adult, pool2	10096-102C6	128.11	6.32	0.00	2.71	0.45	3.16	1.35	1.35	0.45
thalamus - adult, donor10196	10168-103B6	108.19	5.52	0.00	1.10	1.10	1.10	0.00	1.10	1.10
thalamus, adult, donor10252	10154-103A1	136.43	0.63	0.16	0.31	0.31	1.25	1.56	0.16	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	76.98	0.00	0.00	0.00	0.00	1.54	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	62.91	0.49	0.00	0.00	0.16	1.32	0.00	1.15	0.99
thalamus, newborn, donor10223	10366-105F6	54.08	0.58	0.00	0.00	0.00	0.58	0.58	0.00	0.58
throat, adult	10209-103G2	99.62	0.25	0.25	1.50	0.25	1.50	1.50	1.25	0.50
throat, fetal, donor1	10061-101H7	126.15	0.61	0.00	2.44	0.00	2.13	1.52	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	249.01	3.18	0.79	1.19	0.60	2.38	1.39	1.99	1.79
thymus, adult, pool1	10027-101D9	192.07	0.99	0.20	0.50	0.50	3.48	0.80	0.40	1.49
thymus, fetal, pool1	10043-101F7	170.82	1.45	0.00	0.10	0.31	0.73	0.73	0.42	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	109.69	1.33	0.40	1.33	0.27	1.73	1.20	1.06	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	155.76	0.56	0.56	0.98	0.56	3.35	0.70	1.40	1.12
thyroid, adult, pool1	10028-101E1	96.49	0.65	0.00	0.28	0.37	0.84	0.09	0.47	0.47
thyroid, fetal, donor1	10060-101H6	123.92	0.53	0.00	2.11	0.79	2.90	1.05	0.79	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	117.03	0.00	0.00	0.00	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	87.68	0.00	0.00	0.93	1.40	1.40	1.63	1.63	0.70
tongue, fetal, donor1	10059-101H5	90.25	0.39	0.00	1.18	0.39	0.79	1.97	0.79	1.18
tonsil, adult, pool1	10047-101G2	139.24	0.90	0.00	0.20	0.10	0.40	0.50	0.10	0.30
trachea, adult, pool1	10029-101E2	89.98	0.65	0.08	0.57	0.08	0.74	0.49	0.33	0.16
trachea, fetal, donor1	10058-101H4	118.49	1.54	0.00	1.92	0.38	3.08	1.92	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	119.04	0.71	0.00	1.42	0.35	0.00	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	190.17	2.84	0.91	0.51	0.41	1.52	0.61	0.10	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	191.79	2.66	0.78	1.41	0.63	3.60	0.63	1.10	0.94
tridermal teratoma cell line:HGRT	10694-109G1	76.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	86.26	0.42	0.08	0.68	0.51	0.76	0.34	0.42	0.08
umbilical cord, fetal, donor1	10057-101H3	64.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	108.69	1.02	0.00	0.34	0.34	1.19	0.00	0.51	0.34
uterus, fetal, donor1	10055-101H1	158.70	1.54	0.00	0.51	0.00	1.54	1.02	1.54	0.00
vagina, adult	10204-103F6	69.79	1.29	0.00	0.00	0.00	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	92.28	0.22	0.00	0.88	0.44	0.88	0.88	0.44	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	95.87	1.07	0.27	0.80	0.53	1.34	1.34	1.34	0.80